Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Yersinia pestis CO92, CO92

>YPO0698 outer membrane usher protein
MRIIKKIPIAMTTSLIMLSGAVSAIDFNTDAMDANDKQNIDLSHFTNVGY
IMPGEYRLEINVNNHRIPEQVIAFYARDDEPNSSEVCLPEAVVEQFGLKP
DVLQKITFWHEGQCADLRELAGLTTEVDLATSTLAINVPQDWMEYSDSNW
VPSSQWDEGIPGFLLDYNVNSLFSKPKESGSTRNISLNGTSGLNAGPWRL
RGDYQGNYSHNSGEQNSSTSTFDWSRIYMYRAIKSLAATLSVGENYFASS
LFDTFRYAGASLSSDERMLPPNLRGYAPEVSGIARTNAKVTVSQQGRILY
QTTVASGPFRIQELSDSVSGRLDVSVEEQDGTVQTFQVETAAVPYLTRPG
AIRYKTSVGQPSTLNHGTEGPVFASGEFSWGVSNRWSLFGGAIGSGDYNA
VSVGVGRDLYAFGAISTDITQTRASGLPNQETQSGKSLRVRYAKRFDELN
SDISLAGNRFFEREFMSMNQYLGTRYFDNDLGRNKEMYTVTASKNFPDIQ
TNINFSYSYQNYWDQPTSNSYSATVSHAFDAFSLKDMTVNLSASRSKNNG
VNDDVLYLSFSVPLGNQQTLSYSGQHNGQGNNQTVNYSNSSAIDSSYRLS
AGVNNSNDNGARGQFSGFYIHRSSIAETSLNVAYAQDDFTSTGVSMRGGA
TVTAKGAALHGPGMSGGTRLMVNTDDIAGVPLEERNIRSNRFGIAVLNNI
NSYYRTDTRIDINQLADDVEVKQSAVEFALTEGAIGYRRFAMMKGEKVLA
TISLTDSSHPPFGSLVISAKGQELGIVSDDGFTYLSGVEPGETLDVVWSG
AKQCQVAIPAVIQPQAQILLPCISVN
>YPO2486 hypothetical protein
MGRDLLLQSQQDSDNYDAKQQSSSVGGSFSPGSMTGSISINGSQDKLNSN
FDSVQEQTGIFAGSGGFDITVGGHTQLDGAVIGSTVTADKNTLDTGTLGF
SDIDNQADFKVEHQSVGISTGGNIGSQFVGNMANGLLVGANNEGHADSTT
HAAVSEGTITVRDTDNQQQNVDDLSRDVEQANNALSPIFDKEKEQNRLKE
AQLIGEIGSQVGDVFRTQGQIIATQAANEKMQGVSEADREAAKANWEKAN
PGQVATAEDINGQVYKTAYDQAFNASGYGTGGKFQQTVQAATAALQGLAG
GDIAKAIAGGSAPYLAEVIKQSTGDNEEARLAAHAVVGSVLAHLQGNSAV
AGGAGALTGEIAADLIMQQLYPGKMVSELSETEKQTISALSTLAAGLAGG
LTGDSSADAVAGAQAGKNAVENNALGLALKGCGIAAPCRSLIAKQVLEIG
VKAGITGIVAKEIADKISEDDLDHLVTLKMMGNDEITEKYLNSLQDKYAP
AHTGGDQNAGSGPTDTGGNQIADNSPDHTGNDQSTGQGATNTGNTDGKPD
AGGNVLVNPGADPLTKKDIVYLSENPNGKIDTVINETLSGKKNFTSSTTL
TSDEALAAGLKFLGTGYKEIGKSGSGVYHSADGTKEFRIDSGSIDGAHAP
GVPHVHFGVKNPETGKYISNNHVPYKD
>YPO0150 putative membrane transport protein
MQALADYRQLNLITTTGVGGNLSLRLIEVPWEQALAIILRMGRLKAEREG
TVMMVFTEQEIQERQQRTKQQAAPEALANLTLALQYANAEQVADSLDPLQ
GGLLSPLGSVVADKRTNTLLIRDTPASLALLKNWLIEMDLPLQQVQLSAH
IVTISSEDLQELGVRWGMGEGKGNTALRINDFNVNLPLPNSAASVGFHVA
RIGGRLLELELSALEQENQVDIIASPRLITSHQQTASIKQGSDIPYTVSR
GKKEAAAIEFKEAVLGMEVTPKILRNGKIILDLKISQNMPGITIKRGESE
MLLIDKQEIKTQVTVNDGETIVLGGIFQQKKRQSVNKVPLLADIPLLGAM
FRQDTQQQSRRELVIFITPKLISA
>YPO3028 putative autotransporter
MNTNSKKTYLNIAISFILYASTAMNANADSCIDYTVTDICEQSKYAAGEF
HNIKLGDGVTAGSEDHHFVFNGEGYELYNSNANFSAQIASGTIRYTEVNN
SYFTVNAHHFPDDTIYAGRAENTTLNDSLMWVATSADQTLAKGNSMVVVS
TQMAMVDQIFVTTLNDGSLPFDPVITNSRYEDTSYEMLWGMKNEAKGWDT
KATSHDSVFVDASKQSIEANGHSIGATFYGRATQVVKAGGESQDTHLFDH
SYSWVYAEAKLTGLTEVNDAATVYLNAAATQGAYAENVVLNGEDTTLMVR
ASLDNNAYATVDNLILNGGEVVFQQSSGDQYASLNIGTLSGSGSFLFNTS
IAEGKGNFVTIANASGEHKVIVNDSGHEITSPDMTTLDLIHDLSGDATFT
LASISGANIIEVDGGTYVYSLNTWDNSARAGGNLWYLGSGLNTGTELEPE
PEEKTTPSTDAVLSMASSNQFIFDGEMQNLRFRKGDLNNNKGDGASVWGR
YLTNNTRVNAAHDAAYRLQQDGFEIGADKVLEMSSGQLVLGGFTSYSNNR
VKHARGGNSTVDSYSLGAYGTYFDNSGYYVDAVVKANRFKNSLNAHMTNG
GSVQSDYNQNAIGGSLEAGYHYSLSNNWFVEPYVRTSYYTAQDKDIALNN
GMTANIDNNRSAKGEIGTHLGTKIDLNNGAIIRPYAKVAIEREFIKSNTV
TINQVNDFNNDLSGHTAKYGLGMDINLMKQTSVYAEANYRNGTHVESPIM
ANIGFRINF
>YPO1921 probable pili assembly chaperone
MILIARQIIACSMLLLTSVSLSVQASVVMTGTRIIYPEGSREKVLQLSNK
DDHPNLVQLWMDDGNNQSSPSKSDVPFALTPQIFRMEANSGQVVRLTYIA
RNLPKNRESVFYLNFLQIPALKADTLGEKISVTLDTTTGNKIKVHNPTGY
YISLRDAKIVSNGKTVSFATSEMFAPDSTTDLALPIGIKAKKGELLILNV
VNDYGATIPNNYYL
>YPO2181 hypothetical protein
MSQSLLDLSGYIKFFVGLFALVNPVGILPVFISMTSYQAAAGRDKTNLTA
NLSVAIILWISLFLGDAILTIFGISIDSFRIAGGILVVSIAMSMISGKLG
EDKQNKQEKTETAVRESIGVVPLALPLMAGPGAISSTIVWSSRYHSWQNL
LGLTVAIALFAFCCWLLFRAAPLLVRLLGQTGINVITRIMGLLLMALGIE
FIVTGIKAIFPGLL
>YPO0902 putative surface protein (partial)
MNNADDQSCYAIMDGPSVGPITSPNCNTPSIGIINTNAGQLFVGGTGAAV
SGTLGPTFWTGTFATPVGTSNTATAYGMVVQSGGAYITGNTYVQGGLFLN
GQKATNLAPATISSTSTDAVVGSQLYNLVQDGTRYFHANSVNPTDSLASG
LETIAVGPATVVSGDNGVGIGNTALVGAAATGGIAIGFGTQVTAAGATAI
GSAAQAQGAQSLALGAGAVTSQANSIALGAASINTVGAQSSYSAYALTAP
QASVGELGIGTALGNRKITGVAAGSASSDAVNVAQLTAVGDQVQQNTANI
TSLGGRVTTIEGSMASIANGGGVKYFHANSTQPDSVASGTNSVAIGPASL
ASGNAALASGAGAVAIGDGAAASADGSVAIGQGSGDNGRGVENYIGKYSN
ASNTSSGTVSVGNTATGETRTVSNVADGLQATDAVNLRQLDGIAASIVVV
ENNVSGLQNGTDGMFQVNNSSGLAKPSATGANSATGGAGSVASGNNSTAF
GSGAKATAANSAALGANSVADRANSVSVGSVGNERQITNVAPATQGTDAV
NFDQLKSISNQTNAYTNQRYSELKQDLRKQNSVLSAGIASAMSMASLTQP
YTSGSSMTTIGAASYRGQSALSLGVSSISDSGRWVSKLQASSNTQGDFGI
GVGVGYQW
>YPO0690 putative type II secretion protein
MIVPLKIQELMRERMLANIDINKVELLVGDRNKLIGLLSQTFDDLFNNNE
YNLTTQAQKYIIEMIADEITGFGPLRELMEDDSISDIMVNGPERIFIERY
GLLKLTDRRFVNNTQLTDIAKRLMQKVNRRIDEGRPLADARLIDGSRINV
AISPIALDGTALSIRKFSKNKRRLEDLVDMGAMSSDMANFLIIAASCRVN
IIISGGTGSGKTTLLNALSKYISEDERVITLEDAAELNLEQPHVVRMETR
LAGLENTGQITMRDLVINSLRMRPDRIIIGECRGEETFEMLQAMNTGHNG
SMSTLHANTPRDAVARLESMIMMGPVNMPLITIRRNIASAINLIVQVSRM
NDGSRKIRNISEIMGMEGEHVVLQDIFTFQPASTRDDQGRIQGEFINHGL
FNRSSVRINADIHNLANELNSVFSTVSK
>YPO2490 putative hemolysin
MRPTMNKNLYRIIFNKVRGMMIVVADIAASGRASSSPSSGLGHTQHRRIS
ALSTLSFSLLLALGCVSLSVQAAIVADASAPGNQQPTIINSANGTPQVNI
QAPSSGGVSRNVYSQFDVDGRGVILNNGHGVNQTELGGFIDGNPWLARGE
ASIILNEVNSRDPSKLNGYIEVAGRKAQVVIANSAGITCEGCGFINANRV
TLTTGQAQLNNGQLTGYDVERGDIVIQGTGMDSSRQDHTDLIARSVKVNA
GIWANELSVTTGRNQVDAAHQNINAKAADGSPRPTVAVDVAHLGGMYAGK
IRLIGTESGVGVHNAGEIGASAGDITITADGMLMNSGQINSSQQLVVNTA
ADIENTGVLYAQGNTQLTTAGTLSNSGTLAAGGDTSVRAAEVNSTRNSVL
GAGVKSDNSAITSGTLSVEASGKITAQGKNISGTAQRFTAHRLDLSGSQT
QSRDITLIAQGGEIDLTGAELLASDRLSAATTALLRTDNASLIAEQITLD
AQALSNVGGLIAHTGTTDFNLNLPGDVDNRGGTLLSSGTLSLQAESLNSN
GNSLLGAGVQSDGRLTEIGDLRVTTRQDLIAHGQTLAAGAMALTGSRIDL
ADSYTQAREMTLTANRGDISTQRATVLALDTLSINTAQTLNNQGGTLAGN
TLALDLGQFDNQGGQVTASQDLTIDLQRDFSHQAGSTLQAGRDLTLTSLG
AVTNDGQLVAGGTLSTHSDSLLNSGNLIATQAELNATGALINHGEILTLG
GLDTDSNTLFNTGSIISAEATLNARERITNSGPDALIGATDENGTLALLA
PVIENSDTVTHTDTAPTTTILGMGTVILAGGHARDGHYASAAQVLNLSGL
IESGKDMLIYATTLTNSRHILTANTDFIVADTVTGTAVWTAENPDIPGGR
YAEPPDGGADNSDYIGTEYTSVIAYNGIDQISPEAQLLAGGNLTPQVGTL
ENFWSKVSAQGEIDLTGVTLQQDGWGDQQRLMEQTTSSGVWRYRTYKGGL
WTREWGPEVSERATSEYASSFTAKTLSGSGTTINNGANPGAIAPPADRDN
SGKDLAVEFNGISLTQPNGGLYQFTTDHTVGGGGYLIETHPAFANLNNWR
GSDYVLQQLNNDPDVIFKRLGDNAYEQRLVRDQVLALTGQAVASDYRSAQ
EQFEALFAAGLEYSKAFNIALGTHLSAEQMAALTHNIVLMETRDVAGQTV
LVPVVYLAGVKPGDLQANGALIAAENISLTEVQGFTNAGAITATNDLKIS
MAQDITLNNRGGLLQAGGDMQLSTLNSDIDLTSARINATNLQLDSGRDVI
LRTDSAQLSSDNGAVSRDQTILGPLASINVSNNATINTGRDFIMQGASLN
VGQDLQVTTGGDWQLETVQTRDQISTHDGRGSATSEHIRHLGSEVNVGGA
LTANVDNLTAVGANINAATLEVQAQNISLSAATDSLHVTGESSSKRHTSS
VNLYDETLLGSQLNATGDINLQAAQDITLRASAVQTDGALTLAAGGDVLL
TTQTEQHDEQRNHTGLSKGIASSTLTRTEDSLSQTLAVGSMLSAGSIDVS
GKNIAVMGSNVVADQDISLRAQENITVGTAQQSESESHLFEQKKSGLMST
GGIGVTVGSSSTKMTDSGQSISSVGSTVGSVLGNVSMTAGEDLRVQGAEV
LAGKDINLTGKNVSILAAENQLTQSHTVEQKQSGLTLALSGAVGSAVNTA
VTTAKAASEESSGRLGALQGVKAALNGVQAVQAGQLVQAEGGDAASMFGI
SASLGSQKSSSEQHQEQTHVTGSTLTAGNNLTINATGEGNAANSGDIVVQ
GSQLQAGGDTTLDAARDVLLLGAANTQKTDGSNSSSGGSVGVSLGISGAS
SGLSIFANANKGQGSEHGDGTSWTETTLDSGGTLSLYSGRDTSLVGAQVS
GETVKVEVGRDLLLQSQQDSDNYDAKQQNSSVGGSFSPGSMTGSISINGS
QDKLHSNFDSVQEQTGIFAGSGGFDITVGGHTQLDGAVIGSTATADKNTL
DTGTLGFSDIDNQADFKVEHQSVGISTGGNIGSQFVGNMANGLLVGANNE
GHADSTTHAAVSEGTITVRDTDNQQQNVDDLSRDVEQANNALSPIFDKEK
EQNRLKEAQLIGEIGSQVGDVFRTQGQIIATQAATEKMQEVSEADREAAK
ANWEKANPGQIATAEDINGQVYKTAYDQAFNASGYGTGGKFQQAVQAATA
ALQGLAGGDIAKAIAGGSAPYLAEVIKQSTGDNEEARLAAHAVVGSVLAH
LQGNSAVAGGAGALTGEIAADLIMQQLYPGKMVSELSETEKQTISALSTL
AAGLAGGLTGDSSADAVAGAQAGKNAVENNALGSLGDIFGSQGAKYFEGA
GSLERELSTDNTLTVQEKQAIRDHYLKGDLPEDVVKAILENTPASDTVMA
LLQAESTKDYALALLSSLPLERAIAVLGKTANTLIKSSVVDKILDAQRVG
SGLKPDPSHRGASYLNREQLMAGEVFNITGGDGVKRSLLQTKGTFNGKDG
VFEYIYDKTGNVTHQRFIEGVGITGIPNQKAPKVK
>YPO0267 flagellum-specific ATP synthase
MKLPDIARLTPRLQQQLTRPSAPPEGLRYRGPIVEIGPTLLRASLPNVAQ
GELCRIEPQGMLAEVVSIEQEMALLSPFASSDGLRCGQWVTPLGHMHRVQ
VGADLAGRILDGLGAPIDGGPPLTGQWRELDCPPPSPLTRQPVEQMLTTG
IRAIDGILSCGEGQRIGIFAAAGVGKSTLLSMLCADSAADVMVLALIGER
GREVREFLEQVLTPEARARTVVVVATSDRPALERLKGLSTATTVAEYFRE
RGLKVLLLADSLTRYARAAREIGLAAGEPPAAGSFPPSVFANLPRLLERT
GNSDRGSITAFYTVLVEGDDMNEPVADEVRSLLDGHIVLSRRLAGAGHYP
AIDIAASVSRIMPQIVSAGQLAMAQKLRRMLACYQEIELLVQIGEYQAGE
DLQADEALQRYPAICAFLQQDHSLTRDPDTAHLDTTLEHLAQVVG
>YPO1710 putative fimbrial protein
MSAYFYRVKTVIRHINMYLRVYAHVRSVATLLILVVVAGGPSSKVWAEGL
GINCDYTGSIYINPPTSIIRVKPNAAIGDPIGSWMTISAPEVWSCALLPA
YQSRDVRAGILVFSPYNPLLTTNIDGGNYKVFRTGDTNPGLGIAVRFRAI
GAGFSSDWTQLEGFGLVDGTVSAPLIGPIPYNDGIKFPLGMEMQIHYVKA
SEELRSGGVRIFDFAYLYHRRSIDGVPDNSGARYRIVQVPANSIDIQIMT
QTCTTPDVVVNLPEVNSRQFTGIGTVKALKAFNLNFNHCPGGLDGINYKF
GATTSILDSANGVVALDANSTAEGVGVLLRSQSDAAIELDKEYTMSGYDT
SSTQSYTVPMQAGIYQIENTVTPGSVKGEFTFTLIYK
>YPO3950 hypothetical protein
MIAATVLLFLIMDPLGNLPIFMSVLKHLEPKRRRVVLIRELLIALILMLI
FLFAGEKILLFLNLRTETVSISGGIILFLIAIRMIFPSSESNVTGLSAGE
EPFLVPLAIPLVAGPSILATLMLLSHQYPNQLSHLVLALMIAWGLSAAIL
LMSNLFLRLLGSKGVSALERLMGLILVMLSTQMFLDGVRAYLAI
>YPO0695 hypothetical protein
MDVIRLSLIVLIVSQLLFVCYSDIRHRIISNKFIISISFNAIIFSLVMHH
TVSIIIPIVALFIGYIIFHFNVMGGGDVKLITVLLLALTAEQSLNFIIYT
AVMGGVVMVVGLLINRVDIQKRGVPYAVAITAGFLSSVLI
>YPO0266 secretion system apparatus protein
MSKSALVRGLTMITARQDIFLAVMLLVAVFMMILPLPTTMVDLLIAINLA
FSVILLMISIYLRDPLEFSVFPSLLLITTLYRLALTISTTRLVLLQHDAG
EIVEAFGQFVVGGNLAVGMIIFTIITVVQFIVITKGSERVAEVSARFSLD
GMPGKQMSIDGDMRAGAIDSVEAKRLRERVQKESRLFGAMDGAMKFVKGD
AIAGIIVILINIIGGITIGVMQHKMSAEEAMNTYAVLSIGDGLCAQIPSL
LISITAGIIVTRVPGSNKQSLANELAVQVGRQPDALWLAAAILTVFALLP
GFPFLIFITLAAAVAAPAFLLYRKNRRISQDGRANGGSEEGGATGQRMTP
GAVPLMLHCASNLHHPHLGRDIDGLRWRWFEHLGVPLPEVEIRCDPTLAE
NTLSVQVYQERVLEVVLPPDSLLLTRPCSSLVTNNQVLGAKMGSFDWLDA
KQAMQARTLGIPYVEGHQRIITCLTRVFERYTAEFIGVQETRYLMDAMEG
RYGELVKELQRQIPVGKVAEILQRLVEENISIRDLRTIFGALVVWAPKEK
DIVMLTEYVRIALRRHLCRRFSHNKTWISVLRLGDGVEHLIRDSIRQTSS
GTYSALEERQSLLILNKIKNAFAENQDAVLLTTLDVRRFVRKIIERDLFV
LPVLSWQELGDEMNLKVAGTIELIGDELDETA
>YPO0688 hypothetical protein
MRIIFFTLLILLGLIIILKVNSRSRRISVYNKINSRENKSKEANNDTKDK
PTVLSDFIKLPVFLSNILYLKVLIVIFILSILTILAIFNVVNINQKTLLT
IGLLSIISTLYLPRMIIKNALTKRTNNLLKSLPFFIDITAACVQSGMTIE
NSLNYTTQKFQTINTDLCLIMSKVTKRAEINGLENAIKELQYYSPAIEMK
MFCSTLQYSISFGSTVYEQLTHLSQDMREMQLLMTEESISKLSTKLTLPL
FLFILIPFVLLVISPSILELLNYVKNI
>YPO0269 type III secretion protein
MIGSGRQTAGVSVALTEIDGEGVYLPLHYGGQECGLWLSQSCWQHWLNTT
LATDNPQLLAAELVIAMANWAVTPLLALFTDLVVLAESPQKRSLPKQWAV
TVAFELEGQPIIGVLQDWPQAALADTLSHWPCEAVTAPDLLWQSGLVAGW
CHLSLRQLQQLRPGEGLRLSMAAELDKEACWLWHHASPQIYIKLEGGNRM
TIQQINEASDPLACGSRAESPPLAAVQLEDLPQTLVMEIGRLTLPLGEIK
QLAVGQTLACQTHCYGEVNICLNGQSVGRGSLLRCDEKLVVRIAQWGLQN
GENIME
>YPO2044 putative hemolysin activator protein
MLWQMNIFFRKKYMIILLLSNAVLATENNKNRLNDNVVSHADIDVRNEYN
EEGNRVGKRFFSTNHHSVASQKKISPEKICLPITGVFLQGNTLLSSQDLN
QIDHILGECISEDDINILAKEVTRLYLSKGYLAARVNFIPLNNAGELGLN
VTEGIVEKIEGGGRRVNPYFIFPNFIDKPLRLSELDQAIDQANRLRSNKV
NVDILPGSQAGKSIIRINNVNNKPWSLSTVIDNYGYKNSDEWQARVSLAL
DSPFGLSDSINFNANRTLENAKNRYKNDFTVSYSVPYGALTFSALANYLE
YRRYEKLKNGTVNFNGNSQQYNFRTDYMFHRTQKQINSLSMQVEHKQINN
YVDEAKVGVYSYRFTNLELGVNQFRILPHGSVNVNAAIKRGVPWFGTHQK
NKINAVQFTTGKLMVNFNHNFSLLNSPYQFDHALVGQYSKNYAPSPEWIS
LTERNAIRGFSRSSQSADHGWYMKNTLSKHFFMGNILFTPRMGVDGGRAL
KHGSQQGWQSNAGVSAGISMRYHQALFDVEASRGWWLSDSNKQNEPVQVL
GRIAYTF
>YPO2759 putative mannose-resistant/Proteus-like fimbrial protein
MSNFKKSVLVAAVLSLSAFAANAADQGKGKVTFTGSIIEAPCSITSEAAD
QVVELGQISTTSLANMGSSEPRSFSIGLEKCDVATMKNVSVTFDGTPDGV
DAEMLKLIGLADGAGIVITDEAGATIKRGVASVGKTLDQGSNSLKFSAYL
KGTSADEGSVVPGEFSSVANFTLAYN
>YPO0816 general secretion pathway protein D
MYISGKGIKSIHGMIFLFTLIMPLDIISANFSVSFKDVDIKEFINSVSKN
INKTIIIDPTVQGLISIRSYENLDKDTYYQLFLNVLDVYGYAAIEMPHNV
LKVISSKRAKGVVAPLPKEGVTFDGDELINRVIPLRYISAKKITPLLRQL
NDNTESGSIINYDPSNILLITGRAAVVNHLHSIVTDLDQAGDNEIELYKL
NYAIAADVVKIVNEAINPINNLKQEVSIVGKVIADERTNSILISGDTYIR
KKSILMIKKLDKRQSSDGNTKVVYMKYAQASKLLDVLNGISEGFHNEKKT
KQSNQWNQRPVAIKAYDQTNALVITADPDMMLALGEVIEKLDIRRAQVLV
EAIIVETQNGEGINLGVKWENKRSDDINFIKNSDGLLNNNGWGIATTITG
LTAGFYKGNWDVLLSALSTNTNNNILATPSIVTLDNMEAEFNVGQEVPVL
ISTQTTTTDKVYNSISRQSIGVMLKVKPQINKGDSVLLEIRQEVSSIADS
STVNTHNLGSVFNKRVVNNAVLVKSGETVVVGGLLDKKSSTIVNKVPFLG
DLPLIGWLFRQTKEKVEKSNLILFIKPTILRESDDYSVVTSKEYNKYKKD
NMNGYTLADDIVLSDKKYLSVIPSIRKDINNFYTLLDSEL
>YPO4044 fimbrial protein
MSNVKKSTFIIALATLSVIYQALAADAGNGRIKFTGTVINAPCSIALDST
DINVDLGQVANRVLETGNKYSQSVRYNINLQDCSLTAQGSGGATYPALSK
VNVTFSGIADAAAPALLANTGSAKGVGVRLIGTDDALLKVGDTSPDINLT
SGPNQIVFSARIEATSAPVTTGTVVSQATYALNYK
>YPO0272 putative type III secretion apparatus protein
MTDVLPGLTALALAMMRPYGILLILPLFTARSLGSSLLRNGLIVAIALPV
TPLFLSAPIITNSSPVTWIGVLCTELLIGVVMGFVAALPFWAMNMAGFLI
DTLRGATMSTLFNPGMGVESSLFGVLFTQILTVLFLISGGFNQVLAALYG
SYDSLPIGQGIQPAADLLLFLQTEWQMMFELCLCFALPALLVMVLADLSL
GLINRSARQLNVFFLAMPIKSALALFLLLISLPYGLHHYLSRMSDTEQKI
GTLIPLIKGGNDVH
>YPO4006 hypothetical protein
MKLTYIKTKQGLSILPLSIILSLYGSSVAYADNIIPDIQAPAGQQAEVSI
IETPPSTCRALTSYCIGMTETVVNIQAPDENGLSHNKYSKFDVVANGLFD
VTTLNNRLAQEVNGNSFLQDKSATIILNEVNSSHASLLDGNLRVDGGNAH
IIIANPAGINCRGCSFTNASHVTLTTGTPSFSDNKLNSFIVEQGNINIEK
NPSYYMRTGLRYKGADKTYLDLFADTITVSGEINADDGYIVTGKNKVGFS
LPGQPLQVSRLGNENTPVPGTVSLDVSEIGGMYTNKIRIHATDGTIKNKG
AIRANDTLSLSSAANIDNSNGNISGKMVLLSSEGVINNSGGTILNNGEYD
LLPSQGIKITSRGLNNEGGKIEYKNGSVEIATVNTIKNGKGTIKATSTQG
RVRIKLHSNNLNNTGGSIISSGKIEGKVNNIRNNGGAIIGLGGVDLNETV
LINDTGKIISDFN
>YPO1922 fimbrial protein
MKKTLVTLMLFILPGIAFAETSNNTIKFQGEVAEQTCMVDINGTANTPVV
LLPTVSTSNLNQVNSVAGKTNFTINLTGCNIAIQDTQISSVFQGMNVTSG
GNLGNIGTARNVAIQLIDPRGTPIRMSGGSVEVPGITLATGATSASQDLS
AQYITEEGQATAGSVIASAQYAITYP
>YPO2881 putative fimbrial biogenesis protein
MKLTKLWRVCLVVSVLTGCSGTPPENTSQAVAGQTRLQLGLAYLAQGDLT
AARKNLEKAVEADPQDYRTQLGMAFYAQRIGENSAAEQRYQQAMKLAPGN
GTVLNNYGAFLCSLGQYVSAQQQFSAAALLPDYGQVADSLENAGYCFLRA
NQDKQARVLLSRALKYDPDKGEPLLAEAQRHFGEGNRAQAQLLLDVYQHT
LPASAESLWLQIRFAALAGRQDSVQRYGKQLARSFPQSKQYQHFLANEY
>YPO0687 hypothetical protein
MMIFLLSGCLSQQGLSSQGLSTKEFSYRESILIKANNQIGLIKLYRESLK
NKEDESIRVKLANAYYLSGDSHSSLYYLQPISHKPNVSIYLLQIKNLINE
GDNSGATTVLHRLLSIAPHNPEAHNLKGIILANRGDTAGARTAIVQSQAL
FIQEDIARNNIAVISMLDNRYEDAVKILLPDYLSGKRNNLILHNLVFALI
KMGDTRYAKNIIEAERLSDNADELVLALSQVDSFPQEQSFIREK
>YPO0812 general secretion pathway protein H
MFHSQRAFTLLELLLAMIIISGLYYSVLITLPKGSGVVKSEAENLVQGLR
YINQKIRHEGGVFGLKLSETHWRFYKFCCDDCHGIKDNFKINTKINCIWQ
DSGNDKILSREYPDKLTSKLNVYGEDSIIDNVIGDNIKPQLVFSPEEEYS
DFSLVLRNEENSECVEIKNNITGVSLFIHK
>YPO0691 hypothetical protein
MTTGIKIMMFMGVLFIKIDITPLSNHGINIYNGGSMQLILNKDLINKKDN
REKSAVVIISTRKGLKDKISEYVRLADIKNIKEIDDDIFSAASILIPDNV
KGIIIDINENHDINTILDLMKVHTPRDCWCILVGDIDSISIAQQFIERGI
LYLHIQSQLADLTQNLLKGIQIESDRKAFFISILGCRGGIGTTLLSYQLA
HVITQIKKSPTLLLQGNQGSQDLDLITEKKMGEDITGYQKNFDLMRGNER
KLSEVNEHNNKKHNFIIFDQPIHNARKEKTLDYISNSNCIILLIDHSMMS
VRVAKEFIDTLERFKRDNRQAIRLFICLNENRPITKDMLTTSDIQSLLGH
SIDTAIPYINNAKNSLNSPDYFGRKKTKVVELAKQSLGININLSSHTNMW
IREKLNKLFK
>YPO0700 Fimbrial protein
MKKNIFLTLRSERYKAGLLLLLLLLLCTTSKPSFAALQVNSCSLAVSGAG
GETPFVIKALPVTLTNGFVLGSMNFSVVTTFTKTGTTADYLYLGGWSMLA
GGAVMPVSTGVPGVKMSVNVSDALFGGYEWGNTEKATQSLFVPGTKITIA
NRVTVQLIVTDASVYQGGVINWFNVARSFALVSGNAQVWSTKSVATGGSR
CGDMVTFNIGSTNIVLPPPTVATCDLGATDIVVALDPIDTSSLQTQGDRA
GGQAFSIPLGSCAKDAKPYITFTDSSNKANRTNILSLSPSSTATGVGLVL
EKSDGNLVTFGAENASVSASNVGQFLIGTSTAAGGSMPLNLTARYIRAEG
VLKSGNVKADAIFTVAYP
>YPO1707 putative fimbrial protein
MKIKSSNVLIAAFAGLFIAQSAFAADGTITINGKITDTTCGISVNNGTKD
GTVTLPVVSASALDGINSVAGTTPFNIVLTGCTGATMGNAYAHFEQGTTV
EASTGRLNNSDIDGATGVQVRLLDKNSAPIVVGSGNQGNVVEDISGDGAT
LSYYAQYYANEANVEAGLVATNVDYTIVYD
>YPO0810 general secretion pathway protein J
MIKRPDCGFTLLEMLLAVVIFSMISFIIYSSLRVTIKSNNIMGNKVQELI
RLHRVISLLERDISHSVMYIGSQNDYFSNEGRIIGIGVLDSDSFGIYMLR
NNKINTEIFIHYQHERLGYRLKKNCLERLSYLILKNTNKIETKFSCLIEG
INDFRVRIFHQGKWLNEWSRIDLSPQGIEIILDVKGVGVIRRFILLLH
>YPO3721 hemolysin
MKKHTFKLSPAGKLAAAVTIISVSVATCYAAGIVGAGDSAHKPDVSSVNG
TSVINIVQPSASGLSHNQFQDFNVGEKGAVLNNATSAGNSILAGQLAANQ
NLNGQAASIILNEVISRNPSLLLGQQEIFGMTADYILANPNGITCNGCGF
MNTNRESLVVGNPLIEQGSLKGFETFNNNNWLIIQDKGLTANKILDLIAP
RIEVTGMVTSTEAINALSGNNQISTDGQILESRQEDHPNRPTSLGGWFSS
LFSSESEESIDGKYLGSMQSGRINLVSTREGSGVKIAGSLNGSEEINATI
KGKLQLEAAKLGGNDININANSIQAFGNLHKNEDNGGVTQSLERTQLKGK
NIAIVANKKNQLSAVKIDADNVTLRGGELVLDERILTKTEQESSSDGGNG
VLGLGKWNWSENKEEKQQTSIGTTITAKNNASLESTQDDIKLSAATITAG
KNLAIKAKKDLHIDGAIEENSIHDYGHNYKHMVKDESWNNKTTKQTLNKT
TLEAGKNLGLTAENKITTQGIKASAGGDVVIDANDVKIGVQKTSNQETTD
GKHERNLGLGGVDHNNNDKYAETSHSSEITADGNILISVKDDVAITGSKV
KATKDGFVQAKEGGIKIDNAISTTTNKVDERTGVAFDITGSSKKANNSEE
KSTGSEVVSEANLKIISKKDVDVIGSLVKSAGELGIETLGDINVAAAQEK
QKIDEQKTLLTIDGFTSDDGKNQYQAGLKVEHTSESEKTEKVINHGSTLE
GGTVKLEADKDVTFTGSQLNTTKGDADITAENVSFVAAQDTTTSNKEKET
VGVNAHYTGGMDKAGSGAGVSYEETKTDSEKSTAVVSHTDVKGDLNLNAK
QEITNQGTDHNVEGSYAANATNVNNLAAENSETTTTTTNTVDVKYGGNIA
YDGVTRPVEKTIESGKKLDVGGVIENVGNVAPDSVNAGVDLSVNVGEKEN
KSSNSQAVVTSIKSGDISITAKEDVKDQGTHYQADKGGIKIDAANHTFES
AVNRAEESEKVVSGGVDMRIYTTTGEDINVDAKGKGENKQQEVKAEQAQT
GSMKAVGDIIINVQENARYQGTDLDSGDGKIAITAGEEIKFEQATSHLSE
NHNKIDANAKANFGTKPNSKDFGGGLGGGHSQGSTSADIAQVSHLHGKQG
IELNAGKDLTLQGTEFGSKNAATGDVQLTAGGKVDFQAAQSQSSKQDMTW
SASVKAGKSKSNSTSENDDGTKTHTNNKGFSAGAEANVKNTDETSLTHQG
GIINSNGAVTIKADGKDQQAIHLQNTNIISQETILNADNGGIVMESAQDK
EHKNNWNVNTNLNGSQKNTIKSDDQGVVDKDSAKKIHNAAIKLDGGVDKL
DSVTQQNTHINSDKVTLNSAKNTELAGAVLQANQISGQIGGDLNVISREN
RLNKVNVSAALGGSHSNAKQDSLISQVANASPIMSDKIKNKLEEKSTKIF
DKVENKFNTLGKEKDDSVQTISYTKDGQTVKISEADEKKETKDKWWQKGA
KSVGKKIKSAVQDEQVVGGNGSVKANVEVVESQGVEEQSAIRGTQNVDLT
VKGKTDLVGGKISSKNSDVKLKTNGLETQDINGKYTEGGARLNASSSVMD
MISDGAKDVMDGKAPLVSGHGKSEQKNATGGITRE
>YPO0809 general secretion pathway protein K
MNQNGIALLMVLCALFLMSTMVMASYNYWFDIYYLAKNSQQRQKEKWILL
GAEEKFVSKLIKNTSEDRFNDNEFRRLLSGGRVTVGTWNVNFKSIDNTNC
FNINALKTKISNPEEIIETYSWQVFKYLLLISGVGVKETQDTLERVVELY
RSNLVIEQSINGLSTLKEIPYEADEINISSKMNRADFLKIAPVLCIRGDR
KLLVNINMLDAGNSQYLQAALLNKVSARDIYDVISAKPNNGWDNIFIFYD
LLSSHSPMSARNVNKNILDKLTVDEYFINYIFRIDHEDSYYQLITFIHAV
GKSIAILNRRYSFSEQHH
>YPO1387 hypothetical protein
MFTKSNFKKSVVIITAIFSGSVFADVNIGDFNTGVIGNGTAVGNNNSLGG
STNGVVVGNGGSLSNSINGVVIGNGSVSDGDGVSVGGGTSTNGGIAIGSG
SNATRSDEMNIGDRQITGVKAGVADTDAANVGQLVAKAGETLNSANIYVD
NQATETLNNANIYTDNKATETINNANTYTDNKSSETLNSANSYTDNKSSE
TLNSANTYTDSKTAEIFNTTKTYMDGKSKETLNNTYDYVDSKVSSIVYDV
NSYTDKTVNTAFETSLSDAKSYVDDKYNQLSDKVNKNFNKTNAGISGAMA
MSGIPQKFGYEKSFGMAIGAYRGQSALAVGGDWNINHKTITRVNVSADTE
GGVGVAAGFAFGIN
>YPO1708 putative chaperone protein
MRRTLLTILSFLRTVRLLTTLTLLILSVVATVARAEVMISGTRVIYEEKQ
REGVVKVSNTGDMPVLLQAWIDKGDANARPEAIKVPFSVTPPVVRLDPKR
DQTIRLFRTDGGLAADRETLFWFNLLEVPPKPIQSAAGGENKMQLAFRTR
IKMFYRPEGLTVLPAQAAKSLAFSMKGNQIVIKNASPYYITLRKLELRTS
EKGPVLANFTKINNKMVAPFSELSLPTSAKASINNSAQVFYSVINDQGGE
TQGTQKLTQ
>YPO3944 putative invasin
MLNYFRAILISWKWKLSHHTSRPHDVKEKGHPRKIKVVAWITLFFQFAFP
LSLSFTPAIAAANTTNSAPTSVITPVNASILPPAARATEPYTLGPGDSIQ
SIAKKYNITVDELKKLNAYRTFSKPFASLTTGDEIEVPRKESSFFSNNPN
ENNKKDVDDLLARNAMGAGKLLSNDNTSDAASNMARSAVTNEINASSQQW
LNQFGTARVQLNVDSDFKLDNSALDLLVPLKDSESSLLFTQLGVRNKDSR
NTVNIGAGIRQYQGDWMYGANTFFDNDLTGKNRRVGVGAEVATDYLKFSA
NTYFGLTGWHQSRDFSSYDERPADGFDIRTEAYLPAYPQLGGKLMYEKYR
GDEVALFGKDDRQKDPHAVTLGVNYTPVPLVTIGAEHREGKGNNNNTSVN
VQLNYRMGQPWNDQIDQSAVAANRTLAGSRYDLVERNNNIVLDYKKQELI
HLVLPDRISGSGGGAITLTAQVRAKYGFSRIEWDATPLENAGGSTSPLTQ
SSLSVTLPFYQHILRTSNTHTISAVAYDAQGNASNRAVTSIEVTRPETMV
ISHLATTIDNATANGIATNTVQATVTDGDGQPIIGQLINFAVNTQATLST
TEARTGANGTASTTLTHTVSGVSRVSVTLGSSSRSVDTTFVADESTAEIT
AANLTVTTNDSVANGSDTNVVRAKVTDAYTNAVANQSVIFSASNGATVID
QTVITNAEGIADSTLTNTTAGVSVVTATLGGQSQQVDTTFKPGSTAAISL
VKLADRAVADGIDQNEIQVVLRDGTGNAVPNVPMSIQADNGAIVVASTPN
TGVDGTINATFTNLRAGESVVSVTSPALVGMTMTMTFSADPRTAVVSTLA
AIDNNAKADGTDTNVVRAWVVDANGNSVPGVSVTFDAGNGAVLAQNPVVT
DRNGYAENTLTNLAIGTTTVKATTVTDPVGQTVNTHFVAGAVDTITLTVP
VNGAVANGVNTNSVQAVVSDSGGNPVTGATVVFSSTNATAQVTTVIGTTG
VDGIATATLTNTVAGTSNVVATIDTVNANIDTAFVAGAVATITLTAPVNG
AVADGADTNQVDALVEDANGNPITGAAVVFSSANGATILSSTMNTGVNGV
ASTLLTHTVAGTSNVVATVDTVNANIDTTFVAGAVATITLTTPVNGAVAD
GANSNSVQAVVSDSDGNPVTGAAVVFSSANATAQITTVIGTTGADGIATA
TLTNTVAGTSNVVATIDTVNANIDTAFVAGAVATITLTAPVNGAVADGAD
TNQVDALVQDANGNAITGAAVVFSSANGADIIAPTMNTGVNGVASTLLTH
TVAGTSNVVATIDTISANIDTAFVAGAVATITLTAPVNGAVADGADTNQV
DALVEDANGNPITGAAVVFSSANGATILSSTMNTGVNGVASTFLTHTVAG
TSNVVATIGSVTENIDTAFVAGAVATITLTAPVNGAVADGVNTNSVQAVV
SDSDGNAVTGATVVFSSANATAQITTVIGTTGADGIATATLTNTVAGTSN
VVATIDTVNANIDTTFVAGELENIVVSIINNNALANGADTNIVEAFVTDR
FGNGVANQSLIFGTNGASIVGSSTVTTNLDGRVRASATHTVAGSSNTVIA
ISGAHQGYARVTFVADVSTAQLKLTSFLDNQLANGKAGNIAQALVTDAHD
NLLANQSVSFALDNGAVIESQGDASSASGIVLMRFNNTLAGMTTVTATLD
STGQTETLETHFVAGKAASIEMTMTKDNAVANNIDTNEVQVLVTDVDGNA
INGAVVNLTSNSGMNITPNSVTTGSDGTATATLTHTLAGSLPINARIDQV
SKTINATFIADASTAQIIAGDMFIIVNDQVANGQAVNAVQARVTDSYGNP
IKDQTVEFVLSNNGTIQYELDVTSVEGGVMVTFTNTLAGITNVTATVVSS
GSSRNIDTTFIADVTTAHIAASDLMVIVDDAVADNLDKNEVHARVTDAKG
NVLSGQTVIFTSGNGAAITTVNGISDGDGLTKATLTHTLAGTSVVTARVG
NRVQSKDTTFIADRTTATIRASDLTITRNNALADGVATNAARVIVTDANG
NPVPSMFVGYTSDNGALLTPTSGMTDSSGTFSTTFTHTTAGISKVTAAIV
TMGISQTKDAVFIADRSTAHVSELIVVKNDSLANNSDRNIVQAHIKDAHG
NVVTGMNVNFSATENVTLTANTVTTNSQGYAENTLRHNAPVTSAVTATVA
TDLVGLTEDVRFVAGAGARIELFRLNDGAVADGIQTNRVEARVYDVSDNL
VPNSNVVFSADNGGQLVQNDVQTDALGSAYVTVSNINTGVTKVTVTADGV
SASTTTTFIADRDTATLVTDRFLITHDNAVANGVVENRVLLHLVDANDNS
VSGVEVNFSATNGASINASAITDINGFAIGVLTNTLSGPSDVTVTLVTPG
GTESLTVTPQFIADINTANIATGDFVIIDDGAVANSVDANEVRARVTDNQ
GNAIAGYSVVFSSQNGATITTSGITGVDGWASAKLTHIKAGESGILARLS
RPMATVHTLMPYFIADVSTATLQLFNFNPIPIIADGVMQFFVLGRVFDAN
QNPVGGQQVAFSATNEVTLTESNGSISTPEGSVLLSVTSTQAGVHPITGT
LVSNNYTDTFGAAFIANKNTAQLSTLMVVDNNALADGVTRNQVRAHVVDS
TGNSVADMAVTFTANRGAQLSKVTVLTDNNGDAVNTLTNSLVGVTVVTAK
LGTAGTPLTVDTVFTAGPLATLTLVTTVNNAFADNSATNTVQATLKDVSG
NPIVGEVVAFAASNGATITATDGGVSNANGIVLATLTNGTAGVSTVTATI
ETLTETTDTTFIAMKNLDVTVNGTTFNGDAGFPTTGFVGATFKVNSGGDN
SLYDWSSSAPALVSVSGDGVVTFNAVFPTGTPTITISATPKGGGSPLSYS
FRVNQWFINNNGATLNRADAITHCENVGYTMPTSTQVTNAATWMSGKRAV
GNLWSEWGDFSAYTAPGWVPAEFFWLSNNHDASTALAIGLSTGTLTTMGD
FMAITHVMCTRPI
>YPO0273 putative type III secretion apparatus protein
MSTEKNEKPTPKRLKEAKEKGQVVKSVEITSGVQLVALVIYFLLTGYSLV
EQAKALIRSSIIQLQQPLTLALARIGAECMTVLMHIVVVLGGALIVVTII
AGIAQVGPLLATKAVSFKGERINPIQNAKQLFSLRSVFELMKSLLKVGVL
TLIFGYLLMQYAPSFGYLTHCGSRCALPVFSTLMGWLLGSLIACYLVFSL
MDYAFQRYTIMKQLKMSHDEVKREYKDSNGDPHIKQKRRQLQHEVQSGSF
ATNVRRSTAVVRNPTHFAVCLIYHPEETPLPIVIEKGHDEQAALIVSLAE
QSGIPVVENIALARALHRDVACGDTIPEQFFEPVAALLRMALELDYQPSS
DDPPR
>YPO0243 hypothetical protein
MLAAELWLRMTQVKGLGVVKRSALAKRLLASGDIHPGRLAAYGLDSQQCH
QFAQLSPRYIADTLEWLSDPNHHLLTYGEPGYPPRLVHIAGAPLVLFVSG
ELDVLYRPQIAMVGSRHFSHYGEQWGRYFASELARTGLVITSGLAVGIDG
ICHQAALNIQGRTIAVLGSGLENIYPQRHSRLAKEIEYQGGALVSEFLTT
ALPIAAHFPRRNRIISGLSDAVLVVEATLKSGSLITARYAMDQGRDVFAL
PGPLGSASSEGTHWLIQQGAYLATSVKDVSEQVSGSLQWLSLPEEVIISS
PQEQVELPFADVLANVGDEVTPVDVVAERAGQPVQDIASKLLELELAGWI
AAVPGGYVRIRRAGHVRRSNLLI
>YPO0684 hypothetical protein
MQKKTMITFILEKYEFFIKNRQGAILLSFMALIPVFIGLIFLSFEFSHFI
QKRAKLSDALEQASLALSTENNYRNDRASNNRNNYLVTSYAQSYLPSERF
SQPRVVNTYNESLGYTEYNASLQMNYQLALLNSYLKQTPSPTWDVNENGA
ARKYLSSIAEPIDVVFVTDFSGSMDLPFGDIERNNRITKLDELKAIFVKL
NNRIFSNDGINTIGFVPFSWGTKRISANGQVSSTYCHFPYSPKKIDGNGH
YLQRYTASNLKNIPGLDNLSGIDNLAYGQLDEDKHHAILSEIEKKHRDNE
IPTKTRDQAKNFLDKAYKVNQISTITKIVEEHIDYKETINSIDRNGETID
IPMDDILDPFFCLKETNAKSLNFDPNSKGDINEILNMKAEGGTLASSGIL
VGNKMLTESQNNNKLMIILSDGDDNTQKMSSPHDQKAGIINITQKLITEG
MCQKIKDNGIKMVFIGIGYVPDNNIIDWEKDCVGTGNFYLAKNAHELEIS
IERALVVDDEVGRNIPKS
>YPO2491 putative hemolysin activator protein
MRYCYFILHTAILFPLLVISRAGQSAELTPIQQQTLHQQERQRALEERLA
PPTPDVRLSAPSASSDRLIFPVEKPCFVIDRVTLSGTEPLPRWLPLQRIA
NQALGQCLGGQGINQLMSQLQNRLVGHGYVTTRVLAPQQDLNSGTLALQV
VPGKIHRVALTPESDRHVTLFSAFPARPGHLLDLRDIEQGLENLQRIPTV
QASMELIPGSAPGETDIALSWKQSKMWRLAASLDDSGTRSTGRYQGGATL
FLDNPFSLSDQFYVSAGGSIKNRGDKGTNNLTGHYSLPFGYWTAGITASS
YDYHQTVAGLNSDYNYRGESENVSLQLSRLLHRNASQKTTLTYDVLTRSS
KNYINDTEVEVQRRRTSAWRIGLQHRHFISQATLDAGVSYQRGTRWFGAV
PAQEEYFDEGTALSKILQLNAQLDIPFSVMAQNFHYNVQYQRQSSSTPLT
PQDQFSIGGRWSVRGFNGERTLSADRGWTVRNDLGWYTPIQGQEIYVGLD
YGEVGGRGSAYLLGNHLAGAAVGIRGNVLNTRYDLFAGKPLSEPDGFQSD
AVTVGFNLNWQY
>YPO1696 probable outer membrane usher protein
MIIRFRLPPLSVLIYGSILLPSLIPLTILGGSLPPPSTSTTMPDTTLYLE
LVVNDRNFGSTVPISYRNNRYYLSQSQLRTIGLPISEPLAPEIAIDNMAG
VNVKYDGENQRLLINVPSEWLPKQQIEVTEQDDFNLAQSSLGALFNYDIY
ATQGYPYSSLTHFSAWTEQRIFDRFGLLSNTGVYRTHFPSNNNTDDAKGY
IRFDTQWQKNDEEHLLRYSTGDLITGALPWSSAIRLGGIQIARHFAIRPD
LITYPLPQFSGQAAVPSTVDLYIDNFRTQSANINPGPFVINNAPRINGAG
QATIVTTDALGRQISTSVPFYVASTLLKPGVWDFSLSGGALRRNYAIRSA
DYGEMVASGVVRYGTTPWLTLEGRGDIAKEMHVIGGGVNFRMGLLGVLNS
AYSISNTSNGAFNNVAEPLNTNNATPNRLPSPAASRRGRGNQRSLGYSYS
NAFFNLNAQHIISSDEYSDLANYKTPSLLSRRMTQLTGSLSLGSYGTVGS
GYFDVRDALGEQTRLINISYSTSLLRNSNFYSALNRELGRKGYNVQLVWS
IPLGPRGSSSISATRTNDNQWIQQLNYSRSAPSNGGLGWNLAYANSTNNN
NQYQQADIVWRTSMMESRMGLYGNSNNYNYWGGLTGSLVVMNRSVYASNM
INDAFALVSTNGFSNIPVSYENQLIGTTNAKGYLLIPTVASYYQAKFQID
PMNLPADVMLPNVERRLAIGERSGYLINFPIKRISAVNIRITDASGQDLP
KGSAIYTTGNIPISYVGWDGMVYIEQVAQLNNLRIIRADNGTQCYSQFKL
KTTEGIQDAGTTVCR
>YPO0815 general secretion pathway protein E
MTDIESEFHTLPLTFSWSKSHGVLILPMAQGSQLICRKSATLEAILEGNR
VAHSPILFNLVTDEEFENNLTERYQNNSADPYQTMSVISNEIDIYSFANE
LSDDDDLLDINDEAPVIKLINSILVEAIKELASDIHIESFDKKLTVRFRI
DGVLRKILELQRHVALLLVSRIKVMAKLDIAEKRIPQDGRIALNLAGRAL
DVRVSVLPSSHGERVVMRLLDKNSIKLDLPSLGMSKDNCISMNTQVHKPH
GIILVVGPTGSGKSTTLYAALMGIDANEKNIMTVEDPIEFDIPGISQTQV
NPKIEMTFARSLRAILRQDPDVILIGEIRDIETAQIAVQASLTGHLVLST
LHANSAIGAVTRLKDMNVEAFMLSSSLLAIISQRLVRRLCIACRQESSVT
EKVLQRLNIDDKCSLVGSVYRAKGCNKCNLTGYRGRIALHEFLVVDNLLR
GAIYKGLGEFELAKLASGAINSLLSDGISKVIAGLTTIEELVRICQEDDN
GCI
>YPO3878 putative fimbrial chaperone
MLSIYARHYHYLFVTLLVAMSLSFANASVVMTGSRIIYPAAASEHSIQLT
NNDNFPNAVQVWLDSGDEKSTPETGKAPFIVTPPFFRIEANSGQTLRLKY
TGSGLPTDRESVFYLNFLQIPPVNKVEKDNKMLVLLRNRIKVFYRPESII
GRVDQVSTALTFSLRKQGTNLVLTGKNPTGFYATIASGEIVSGSIKLKVK
SNMIAPMSQVEWVIPNASVSSSATINFLIMNDFGGQDAGSYRI
>YPO0683 ExbD/TolR-family transport protein
MAMRMNDSLDESGELHEINVTPFIDVMLVLLIIFMVAAPLATVDIKVDLP
ASSAVPQPRPEKPVFLTVKADNQLYVGDQPVDRETLATALDKVTQSNKET
TIFFQADKVVDYETLMSVMDALRKSGYLKVGLVGMEAGSSGAK
>YPO0811 general secretion pathway protein I
MLEVIIALTIFCIAGLSIMKIISERLRWINILEQRMISSWVAENVLTEIK
ILKIEQTNEWLMGQESMAGQLWYWQSRSIKLQDDRMEIIAVEVRNNKESE
HPDFSLEGYKTTND
>YPO0257 possible type III secretion protein
MIVGLRQKPYLNLRNYKWMSLIYIMRKITGLILLFFATLLPYGKFSYVKA
IPWQGEPFFIYSRGMTVSELLKDLGMNYGIPVVISSEINEHFTGKIRDKT
PEKILSELAGRYNITWYYDGETLYFYPVQSIKREFISPDGLAANTLVKYL
QRGDVLAGKNCAIKAIPHLDTLEVKGVPICIERVKSVSKMLSEQVRHQNQ
NKETVKVFPLKYASAADSDYQYRDQNVRLPGLVSVLRELNQGNNLPLAGG
NQPDGNQASSPVFSADPRQNAVIIRDRQANMPIYRSLITQLDQRPIQIEI
SVTIIDVDAGDISQLGVDWSASASIGGTGVSFNSTFAKNNAEGFSTVIGD
TGNFMVRLNALQKNSRARILSQPSVVTLNNIQAVLDKNVTFYTKLQGEKV
AKLESVTSGSLLRVTPRMIETEGVQEVLLNLNIQDGQQQASTNSNEPLPE
IRNSDISTQATLQVGQSLLLGGFIQDTQIESQNKIPLLGDIPLLGGLFRS
TDKQSHSVVRLFLIKAVPVNAGE
>YPO0263 type III secretion system apparatus lipoprotein
MKSLRQMLAIVLMTLSLSGCDMELYSGLSEGEANQMLALLMLHQINAEKQ
IEKSGMVGLTVDKRQFINAVELLRQNGFPRQRFITVDELFPANQLVTSPT
QEQAKMVFLKEQQLENMLSHMDGVIHADVTVAMPMSVDGKNPLPHTASVF
IKYSPEVNLQSYQSQIKGLVRDAVPGIDYAKISVVMQPANYRFSASEAEQ
QQGPQTTVQWLLRHVGMVQNMVGVAFISLIVLMFVGWFYYRRR
>YPO1388 hypothetical protein
MNKEIKRMQRMQCIYIATWLIAVFTSPIVIANNTNINGSTNNNGNGTINI
FDASSNNDIHTLTGLGNEQLGGFSNHLIDSHNNTIDGGQSNNLVSSDGNM
ISAISLGDGLFYGAQNNTLINSNNNLLIVTQGSTIIDSDSNTVSGISNNL
IESNSNIIGNENSCYSDPASPSGAWCVDNQNTLIGSDNNTITGALNGLHN
SHNNDIIASSVNNLMDTHNNIIAGGHYNTISGGGNNDIFGSENNVTDSTD
ANINGSNNYVIDGNGIGRDDLTEDNSILGGSGNMGVGDSVTAITNSVVFG
GNTSGNSTGSTLTDSVSVSGNGTSGNNVVNIGGAANGNNSASLGTGSVSS
EGGIALGSGSIATRNDELNIGDRQITSVKKGVENTDTINVSQLNDSFDDV
LNLSNEYSDNSFSTVTENINNYTDASLDTVLNTTGEYTDNSILLVTNESN
NYTDNGMESVSNYANIYADESLLAIYNEEANYMSNLIDVTLNNANNYTDL
SVNTIIYTGKQYTDSRINEYQRTFKNEFLTYSNGKFGGFDKDINQKQKQL
NAGIAATMAAAVIPQKSGSKVSIGVGLAGYSDQGAGSVGAIWHVNQRITM
NTTMTYDTQRGVSLLTGLSIGI
>YPO2542 hypothetical protein
MWVLPINSNPTVLHPPMVDRVYIDRQIDELELYFCPDTGKCKKLTTEMRV
RNEIYKNLDYFYYFLEKSYTSVALSLLIVEQAWTNTHQPVSRGNIKPEYR
LDDYRRESLCEFAIREILKTVDEAIISQPSTTDSFTKKKNKKAYEDIISM
VSYLVGLTKDKIQGAKQRYGSDPITQVLFQEFNKRNIFHDYSGNEQDVLK
DAMNGIVYSCYKFYSEKEKLPSVDVIKKIMKEVPQSINYPDSETAAYRLI
SKAIIDPMIIDINYEKHCHLSHLNALARTLIAKDIPITHNRKYKHYLTDN
LNNKFIRLFLLDKTFDIRKSELYQRVEQHLREINENISADDILRCCKDYY
EFAREKYALKIPSLAEVEFTEQLTRSGHISAAIEHRRHGTYLPRTV
>YPO0270 putative type III secretion apparatus protein
MELLNSSYQLIALLFMLSVLPLLVVMGTAFLKLSVVFSLLRNALGVQQVP
PNIAIYGLALVLTIFIMAPVGLDVQARLQNEELSNDIGALAHQIDQNALV
PYRDFLQRNTDIEQVTFFNDIVQNKWPERYRDSVKPDSLLILMPAFTLSQ
LNEAFKIGLLLFLPFVAIDLIVSNILLAMGMMMVSPMTLSLPFKLLVFVL
VDGWSLVLGQLVGSYL
>YPO1015 putative prepilin peptidase dependent protein
MPLVVNVLSTPLNAQPTRTAGFTLPEMMLALSFGSLIALSTAQVLPKLSQ
QISVLQQHYRLELVMNQAMGAMEKDLRRAGFCHGKCQGEAITIEHYLGET
AHSCLIVAYDLNCNGRWEGAKHQESEYFGYRLRNKALESQRGELNCHGRG
WEKLFDPRDVTVTHFSVTPLSGQLFKLRLVGHKTGNPAIHHQVTYLIRGN
NV
>YPO1672 hypothetical protein
MLKHFRLGLFTANVQADTGSQHSFSRVPAAAINPITLAIVVAFSTIALPP
MALAACTSPGVGTYVCEGENTDGIILSGTDIAVETQPGFSIIVPENGDPA
LSLVGSGTISYLDTNSSALDTTGADSLYIQNDTHTTGQSSSINVQTNGSM
GSGINISNHSGADSTVQVDVSGTLFGDLNGSPALLIYSSAENNSTILMNI
NTIFGDVGIRSDNTSFNGTAITNVDIANDINATYSGATINNSGSGGTSVV
NFNSKSIITELDALNIYNTNYSGAVITNVDIDGDVISTTSQATSFYNDAY
NGSANFTFRANNVTGEYSGISINNSSHNSANNNHDNAVITDILLTGDLTS
TSGSGLQINSYMDDGDIKVSAQLENIYSYYEALSVRADTLTGNLQFNIDV
SGNIVAENGLGFMVMGGASEGNSTMIINANNISSGSQALNIYNYSGLGSA
FTAVTATGHLVSEQGIGAMFSTYVSQGDATAVINLNDITTAGSGVKIDTI
ANGGNSTTYLTVVGQINSSLYDGIDLRATATEGNTLVSIDVNNIASEYDA
IHLDNKNYTTGADNGTSTIDLITRGALVSQQGYGINIETNTADTYVTVGG
LVHGGNGTAIGIHRLDNIQTSATLELQSGYALEGVTQALVFNGSYAEIND
AALDLANSHLVLGGAGDAAFDLTRIDNREEAILDGDPNRIIGFGTLTKTN
NSIWTLTGANMADGDANAFLSANIAGGILVLDNATLGLTPDAGALTGATV
NRLSAADIAADPTLVATETGALTLAEGGALSSLGDSVLSGNLISAGGILL
SNHYTGGNGAATDDRLTVTGTYFGENNGSGEGAWLALDTVLGDDDSATDR
LVINGDATGTTSVRVNNAGGLGDKTLNGINLITVDGLAQDDTFLLAGDYV
TTDGYQAVVGGAYAYTLQADGEAATAGRNWYLSSELMLTEGVRYQAGVPL
YEQYPQVLAALNTLPTLQQRVGNRYGAPGALADLDFDNNQWAWGRIEGSH
QVTDPARSTSGSQREIDVWKLQTGIDVPLYQSQDGSLLTGGVNFSYGKAK
ADIHSFFGDGRINSAGYGLGTSLTWYGNNGVYVDGQLQTMWFDSDLSSRT
AGHAVASGNNGRGYTSAIEAGKGYALGNGLSLTPQMQVTYSRVDFDTFRD
PFDSEVSLQEGDSLRGRIGVSLDKETTWSAKDGTTRRSHIYSHLDLHNEF
LNGSKVQVSGVEFATRDERQSVGLGAGGTYEWQNGRYAVYGNVNLLGATR
NVSDNYAVGGTIGARVSW
>YPO0806 prepilin peptidase
MMDIQVFFVSYLIFGAMVGSFLNVLIYRLPIMLANLSSRSESHGEEIKMR
SHLRNINLFQPGSFCHHCNESIPIKYNIPILGWIFLRGASRCCNKKISTR
YLFIEVLAVIQTLLVLMIFKEDLLICTSLVLIWSLTALAFIDFDTYLLPD
CMTIPLLWLGLLINIDTVFAPLTSAVLGAVSGYLFLWLSYWLFKIVRGVD
GMGYGDFKLMAALGAWFGVSAVPFLILFSSFFGLVAYAIFYFFDKKDNGK
EINYIAFGPYISLAGVLYLFLGSHVTNLFS
>YPO4041 putative fimbrial chaperone
MKDINSMIWRQQRLWAKTALFGIALWLTALTSQAAINLDRTRIIFNSTDK
SASVILQNQSPSSPYLAQSWLENTKGQKIESPLVALPPMQRIDAGQKSQV
RIMKLPDADKLPTDRETLFYFNVREIPPQSEMNNVVQIAIQNRIKLFYRP
MAIKANYSDIWQEKLQISKLVGGLKINNPTPYYITLAYLSQNEQGNFPGF
DSVMIAPFGTEFVKTPGYSGSRYNVGYMDDFGGIVIRTFNCLSAECQIQP
AEKRR
>YPO0940 hypothetical protein
MFSRIKAKRIDLENPDLASDGFNKQDFANKVAASVDHNASDLHLCTGFHP
VLRIDGELKTFTDWPKVTAGWLNGLRRHMLSDAQESRLQQQGQVDCAYTT
VGSQRLRANIFQQRQGQSIAFRIIPAICPSLTQLAAPPILNQLIQQDNGL
ILVTGATGSGKSTTLSAMISAINQQQARHIITLEDPIEFIHSSQSCLIQQ
RELGRHTHCFSRALNGALRQDPDIILLGELRDLETIRLALTAAETGHLVL
ATLHTRTATQAIDRLIDVFPPEEKAVIRTQLAASLRGVITQKLCRQNGGG
RIAVFEILTQTTAVSHLIREGKTYQLPTVIQAGGQWGMQTFEQSIAQRQK
QGVLAINH
>YPO2940 fimbrial protein
MLTTVFIAQSQPAQAASSCAGTADCHIQVSFGGEYVEDTCEVSINGASSA
ESVSLPTLSTSKLNIDGAEAGNQAFQIALKLCPANRSVDLRFTAADSSRN
PDVITGNLQNELADDYSRNVQVRLSKATGQQMFVGRENSVQEYVIPATGE
DITHYFLAGYYAKGTNAVTPGQVKATAGIELVYK
>YPO3084 hypothetical protein
MLEEIAVNPNWFWLSLGGLLLAAEMLGASGYLLWSGIAAVLVGVLVWLFP
FSWEMQGVLFSILTVVSAFLWWYWLSKRTKPQPAMLNQRNHQLLGIRATL
TEPTVDGYGRMKVGDSSWRIYCATELNPGTEVEVILVEGNTLHVRAVNR
>YPO0587 putative autotransporter protein
MKNSNRSPKNISRNFKHHKETSLSSKNKSPIATCVAAALFIFGSSSVIAN
PDHEGIVVGKSILNKKQSAVNAIINEGNSLVLTDSASAEHTAVNTGSIFT
LKEDSTADITSVTGGFFSLSGSSKANINTVLSGGWLEVNDDASITETTIS
SDIEKKSTVRLYQDGSATKTTVGDNGILYVSGDSRAEETHVTKGGKLIVY
SESQGPTLKNTQIAGTLTLKSDVTLEGKTEFVSSATIKTTGHLIDNQGQL
IFNSDKDIVIEAMIDGQGSLTKENPLTTLTLSSAGDAWVASYVYSGETHI
NAGNLKLANTHFFGSPISGNPNTRLILEKSTLDTTVQGSSVFIDKHSIWN
MLGDSNIHHLDILDSGRHDLNNPGKTGNQLIINGDYFSDNGTLIFHSQLA
GDDSVTDHILIKGNTGGHTNVRVINVNGEGNKTDSGIQLIEVRGISDGEF
SQVGRITAGAYEYRLGRGKDELSKNWYLSSDITDYSSDGVPEAELPGILV
LKSDNAAVFSAKLADYALQAVGGVVDSFTQPETSPPSNTPELTVPDPKRA
NAAAFSAKLADYALQTVGGVVDSFTQPETSPPSNTPELTVPDPKRANAEA
FSAKLADYALQAVGGVVDTFTSPEQTEQTTATPDSTPKSTDSAVKPASTP
KPTDLAVKPANTVISNAKTAAPKRQTLVHTPENGSYIANIAMARNLFTTR
LEDRTSHYLYKDIVTGQWQPTSMWMHTQGGRSQFGHTVEQLNIKGNYYSV
QLGGDIAQWATNEQGSGRIGMLAGLGKATNHSHSKVTSYHSRGAVDGYNL
GIYATWFADQQHNTGVYIDTLAQYSWFNNAVNGQDKAEEKYKSSGFTTSI
ESGYTFNLANSDQLSYFIQPNAQITWAGINAQTHKTADGAVVSYRNNGHF
ITRIGAKAYLQTHDTLNTKFTPFVAVNWIHQNQNTGTTISGQGIDNKIQN
STEFNVGVESQIDQQLHIWANINHQIGRYNYTDTNALVGVKYHF
>YPO1709 putative outer membrane usher protein
MLSAFIFFQKNECLKYLPAFSFAICGIGGMLYIPSSAAENSEYVEFSDAF
LRFPVDATRYSEGNPVSPGERQVDIYLNDQWIGRQEMRFALPSPESKVAT
PCFDVKLFDELGVDTAKLSSDTVKLLESRGACSPLSRLLEGGNAIFDDNQ
QRLDIQVPQAYLIRQARGYVHPKYWDDGVTAATLKYDYTGYRSNQNDIGS
QTYQYLGLLGGLNWQSWRLYYRSALNRSDSQGFDYQNLATYVERAVPSLY
SKMTIGDSNTDGQVFDSLSYRGIELTSDDRMYADSQRGYAPVVRGVARTN
ARVVVRQQGRPIYETTVPPGPFVIDDLYPTGQGGNLNVTITEADGSEQTF
IVPFASIAELLRPGTTRYSLMAGEYRDNSMVDKPVLFMGTVRHGLSNLLT
GNGGMVAAEGYLSASAGLAFNTPVGAVAFNVTQAQTRLPNKDNQRGQSIG
MTYAKSLPETNTNLTIASYHYSSNGFYTPAEAMRMRDYLQHGEVNNTQID
SSWPNGSDRYDDSFKYRRRNQAQVSIAQGLPDGYGSFYANANVQDYWDGR
NRDMNFQFGYTNSYKSLSYNVALNRLRDIPSGDWDNQLSVSLSIPLGTHA
GAPRLSSSYSNTRGSSAIQTGVSGSAGEDNQFSYGVSAANNRSDENGSYN
TLGANGSWQAPYATVGGSYSKSNSYDQASASLSGGVVAYRGGVILAPALG
DTVGIIEAPDAAGARVGSYSSMYLDRRGRAILPYLSPYRQNEVELDPKGL
SADVEFKSTSQKVAPTAGAVALVTFETSTGYSVLVRGHLADNTPLPFGAE
VKDGGGTRVGFIAQGGQAMVRVNQQAGNLRVIWGDGIGESCSFDYKLPEG
NLVKGHLVKGDYRRLEVICK
>YPO0617 hypothetical protein
MMTHAVLTARIAKISLTCSILSWSLLIVGCATDRLDLAPASYTEPWTPDG
NARASMGGGNFSVPPNPIVAELAQPPTIKSDHAYSLPELIDIAQRQNPDT
RIAWQQARQAALAVGMGEAIFLPIISASVIGGYQRTTTPLPYAIGNEKDL
KTTGSAVIPALALQWLIFDFGQRSALLDAAKQTSYAANVTFNGMHQKLIY
DVTRTYFQYGAAQAQSQIAKQTLQNSLKIQDAAEERQKKGIATTVEVALA
RQQVAQSQLRRVVAKGTERDAYQALLGAMGVSPSLDIKAAYTEDRALPDG
ISAPTEKMIQLALSQRPDVLASYAAVEAAKAGIKATEADFLPKVYLAGAV
AGGDGHFDIQGLPGISPQTSSSSILVGVSVPLYDGGIRAARVKEAESRAA
VAAEGFKKTQELAVREIVVAADTLRSALESNQAALNLVKTSFISYDAALE
SYRSGVGTITVANEAANGLLNAQQMSTDAHAASLVAAANLAFVMGKMTNT
SPPLELLH
>YPO4005 putative hemolysin activator protein
MIFKINVRWRDKIGDFWWGILCLLYLQIMIGMLPFKVFAEMALPEMDLLE
MDIAEPQIPNSIIPPLSHAQLASEPVLPENLYNDEVQCVAINNVELINLD
AFPNAAHLKEKAEEAHGRCLGEQGLSVLVANLQQQLVVDGYITSRVVFVD
DSERDGTLMLKLMPGRIEDIRHHQDSVGNAHLSSLFPGKRGDLVNLRHLE
QGLENLQRLPSVNATLDVELNRDDLSSQIIVNRQQSRLWRINAYLDDAGH
DAVGRYRTGLILSFDNPLSRYNPLSLSDLLYFSVNRDLDSQPDKGHNSYG
VHYSVPYGNWLFSMTGNQGERYQSFSFAGKRLAGKKFGYRSHWSVLDTQI
QHLLTRGVNYKTVGYAGVLIRQSASFWTHREIDIQRFNTTDWQLGIEHLH
YMPWATFRGGVRYQQGASWFGAQPIPGKMSTAPARLVDITSSLDIPFKIG
TQSFQYRPAFSQQHTYSDISSLDKFTIGGRSSVRGFNENNALTGSRGWSL
KNDISWISPIPGQTFVGQQFYIGMDYGEVSEQGQPFLLGERLAGAVVGTR
GNYHAFGYDFNVGVPITKPAEFDADPLVFGFTLTWQY
>YPO0309 hypothetical protein
MNPITLAIIVAFSTLVLPQTAWAACNSSGVGTYVCEGENNTAISLFGTDI
AVETRPGFGITEHEITDSALSLTGSGTISYLDTNSSALDTDSRYSLYIKN
DTLITEQSASINVQSNGSISSGVYIDNQSSDDSTIRVDLSGILSSSLSGA
PALSIFSSAGNDSTIILNTHAISGVTGIQSDNNSQNGATITHVDVTGDIN
VENSGVSIRNAANGGTSIINFNSKSINTEYNSFYIQNTNYVGGVITDINI
DGDISSANSQAARIYNYTNGGLASLRFRANNVTGSTGLYIDNSSQNGAVT
DIILTGDLTATSGSALQANAYSDEGNIETAIKLNNVYSLYDALNISDYTR
SGNILHDLDISGTITAENGTGIKVMGAAGEGSSTMLINVNNITSSSQSLD
INNYNFLGSAFSAITATGHLTAEWGQGAMLQTHSSLGDATTLIHFNDITA
MSSGISLINEANQGTSTADITVTGQINVSHGEGITLNALTTDGRTLVNVD
VNNIASEYDAIRLYNYNYNDNYATGVDDGTGADNGTSTIDLITRGALVSQ
QGYGINIETNTADTYVTVGGLVHGGNGTAIGIHRLDNIQTSATLELQSGY
ALEGVTQALVFTGSYAEINDAALDLANSHLVLGGAGDAAFDLTRIDNREE
AILDGDPNRITGFGTLTKTNNSIWTLTGANMADGDANAFLSANIAGGILV
LDNATLGLTPDAGALTGATVNRLSAADIAADPTRVATETGALTLAEGGAL
SSLGDSVLSGNLISAGGILLSNHYTGGNGAATDDRLTVTGTYFGENNGSG
EGAWLALDTVLGDDDSATDRLVINGDATGTTSVRVNNAGGLGDKTLNGIN
LITVDGLAQDDTFLLAGDYVTTDGYQAVVAGAYAYTLQADGEAATAGRNW
YLSSELMLTEGVRYQVGVPLYEQYPQVLAALNTLPTLQQRVGNRYGAPGA
LADLNFDDNQWAWGRIEGSHQVTDPARSTSGSQREIDVWKLQTGIDVPLY
QSQGGSLLTGGVNFTYGKAKADIHSFFGDGRINSAGYGLGTSLTWYGNNG
VYVDGQLQTMWFDSDLSSRTAGHAVASGNNGRGYTSAIEAGKGYTLSHGL
SLTPQMQVTYSRVDFDTFRDPFDSEVSLQEGDSLRGRLGVSLNKETTWSA
KDGTTRRSHIYSHLDLHNEFLNGSKVQVSGVEFATRDERQSVGLGAGGTY
EWQNGRYAVYGNVNLLGATRNISDNYAVGGTIGARVSW
>YPO0146 hypothetical protein
MDTFFYSVSTWRSIKMYSQYWQVGLDIQMEAIRALAVIRRRNGWQLRYWW
HKILPSGVLREGILHQPDILSEQLKLLRKQLPRHISLRIALPAQRILQHT
IHVPDRRLREPERDGFIKASASRLFPVNSQALALDYCRETVASSELLITA
ARQSEVQQWQACLEQAGLSSQVIDIAPCALRYMATATGLSGPYWLVHRLA
NEWLWVSSSDMPFHSGVVAIETECRTQENDIRLLSALLAQLNMRGAGEDG
APLPVYYSSVVKESLPENTRSWSPLTAFAHYQPPLPALPAAFTLAGGLAV
RAADSLSAAGAGY
>YPO0599 putative adhesin
MNKNLYRIVFNQARGMLMVVADIAASGRAASSPSSGVGHTQRRRVSALSP
LSFRLLIALGCISLSAQAAIVADGSAPGNQQPTIISSANGTPQVNIQTPS
SGGVSRNAYRQFDVDNRGVILNNGRGVNQTQIAGLVDGNPWLARGEASVI
LNEVNSRDPSQLNGYIEVAGRKAQVVIANPAGITCEGCGFINANRATLTT
GQAQLNNGQLTGYDVERGEIVIQGKGLDSRGQDHTDLIARSVKVNAGIWA
NELNITTGRNQVDAAHQNINTNAADGRHRPAVAVDVANLGGMYAGKIRLI
GTETGVGVHNAGEIGASAGDIVITADGMLVNRGQISSAQQLAVNTPSGIE
NSGVLYGKGNTQLTTAGKLSNSGTVAAAGDTLIRAAEVNSSRNSVLGAGI
KSDNSAITRGTLDIKARGQLTAQGKNISGTAQTFNANRIDLSGSQTQSGD
LTFTTEGGDIDLTGANLFANRRLSVSTPSLLRTDKANLFAEQIALDAQAL
ANVGGVITQTGLTDFNLNLPGDIDNRDGTLLTRGNFLLQAEHLTSNSQSL
LGAGIQSDGKLAPRGDLNVTTRHALIAQGKTLTAGTLALSGSRLDLTDSL
TQAKYMRLTATEGDIALTGATVMAANTLFADTRQILRSDKAYLTADQINL
TAYSLSNVEGRVVQKGSGDFRLDLPGYLDNRGGVLLTKGNLALQAERLTS
NSQSLLGAGIQADGSKASKGDLQANTTQALIAQGQNVAAGTMTLSGSRVD
LTGSQTHASNITITARDGDVTTREATLITPGTLSMTAVANPEQTLNNRGG
KLHADNIQLNLAKLENSNGEIAAATDLWLRLQSDFIHQAGARLTAGRDLL
FNSRGALINQYKLEAGRDMQLTALSIRNTSADRNTNADNSSLLAGRGLSL
STDSLFNRGAIYTTGVGQFTVNGNTENIGEIYTEQQLTFTATGNLANRGV
MQTRGEMQLSAQGDVNNSGMLYSAGDQMRLSIAGNLTNEGKLHVANGEMR
LLTEGNLDNRGSLYGAGNSDITTQGNAVNTGSVYTQGALQWLTKGSVRNS
ASIAALGDLQLRANDLLSDNQSLMAAGLKADGSRSDSGNLAVSTEQALIA
QGQNIAAGSLALAGSQIDLTGSQTQANAISLTAKSGDITLTSAVIKAATQ
LLVTQLAATRSSFIPPSSIPPSSTQSSSTQASASPSAWLRTDKASLIADQ
LTFDVQALSNLGGVIAQTGATDFNLNLPGYLDNRGGTILSKGNVAIQAQG
LDSDSGSLLGAGVQSDGKLTNAGDLAVTVRQDLIAHGQSLAAGAMTLTGS
GVDLTGSQTQARGITITANKGDVSTQRANILSLGSLAINAGANAGQTLNN
QGGSLQANNIALNLGQLDNRTGKIAASQDLVLGLQSDFNILADSTLQAGR
DFSFTTHGALTNDGQLLAGRKLSTRSNSLLNNGNIRAVQADLRASGALTN
RGEILTRGGLSTDANTLFNSGTLIGATATLNARERITNSGPNALIGATDK
NGTLALLAPVIENSDTVTRTDTAPTTTLLGMGKVILAGGQDNSGNYSSAA
QVLNLSGLIESGNDLLVYAKTLTNRRQILTATTDFIVGDTETGAAYWTAE
NPDIPGGRYTQPPAGGPMNSDYIGTNYTSTVAYNRIDQISPEAQLLAGGN
LTLQVGTLENNWSKVSAQGVIDLTGVTLQQDDWGSQQRLVEQTTSSGEYR
YRTYKGKLWGIAWGPEMKLRLNNQYASSITAKTLTGSGTVINNTVINNGA
APGAIVAPRDRDSTGKNIAVEFNGIALTLPRSGLYQLKTDKGDYAPGPEA
ALSLANISPPSSLDATGPRGVPPPSDDLNRTGLVTPDRAVSGGYLVETHP
AFASLNNWKGSDLYLQQLSSDPSVIHKRLGDNAYEQRLLRDQVLALTGRT
VASDYRSEQAQFEQLFAAGVQYSKAFNLAPGTRLSAEQMATLTGNIVLME
NRDVAGQTVLVPVVYLAGVKPGDLRANGALIAAENISLTEVQGFANAGAI
SASNNLQISMAKDITLNNRCGLLQAGNHLQLSTLNSDIDLTSARLNATNL
QLDSGRDVILRTASDQYSSGNGAVQRTQTILGPLASLNISNNAVITAQRD
FIQQGAGINIGKDLQVNTGGDWLLSTVQRSDQISAQYGGGSATSGSLRHL
GSEVKVGGALSANVDNLTAVGARVNAGTIDVRAQNITLSAATDSLSVTGG
SSSKRHTSSVNLYDETLLGSQLNATGDINLQTVNDITLSASAVQTDGALK
LAAGGDVTLTSQTEQHDEQRNHTGTKKGLLSSTTTRSEEGRSQTLAVGSM
LSAGSIDVSSQNIAVAGSSVVADKDIRLRAQENLTVSTAQQSESGSQLFE
QKKSGLMSTGGIGVFIGTSRQKTTDQTQTVSHVGSTVGSLTGNVRLEAGN
QLTLHGSDVVAGKDLALTGADVAISAAENSRSQQYTAESKQRGLTVALSG
PVGSAVNTAVTTAKAAREENTGRLAGLQGVKAALSGVQAVQAGQLVQAQG
GGITEMVGVSVSLGSQKSSSQQQQEQTQVSGSALTAGNNLSIKASGSDIL
IAGSQLKAGGDTRLDAARDVQLLGAANRQKTDGSNSSRGGSVGVSVGGSG
LSVFANANKGQGNERGDGTFWTETTVDSGGMFSLRSGRDTALTGAQVSAE
TVKADVGRNLTLQSQQDRDNYDAKQSRASGGISVPVAGGGAAVNLSMSRD
RLSSQYDSVQAQTGIFAGSGGVDIRVGEHTQLDGAVIASTAAADKNTLDT
GTLGFSDIKNKAVFTVEHQGGSLSTGGPVGSDLLSNLGGMVLAGLGNGGY
AEGTTQAAVSEGTITVRDTENQQQNVDDLSRDTGNANGSIGPIFDKEKEQ
NRLKEVQLIGEIGGQALDIASTQGKIIATHAANDKMKAVKPEDIAAAEKQ
WEKAHPGKAATAEDINQQIYQTAYNQAFNESGFGTGGPVQRGMQAATAAV
QGLAGGNMGAALTGASAPYLAGVIKQSTGDNPAANTMAHAVLGAVTAYAS
GNNALAGAAGAATAELMAPTIISALGWDKNTLTEGQKQAVSALSTLAAGL
AGGLTGDSTADALAGGQAGKNAVENNLLGGNEFTHTQFVQKHGADVLSCA
DNPSNAACQRGIAENKAYIAALATGSVALLPGSSQAMWALGAGTNAGMQY
ADNGKINPVNSVAAGWINVITMGQGWKGTIAWNAAGGALINAINGGDPLT
GAITNGTGAGFGYGVGNYVVKPAANTLGKWITGGWNPKFDPNLLKYAEVK
GQLGISKEMLPSKIPSAVGNAGGSLSSEFGSSLIQQKKDAMEDSK
>YPO0689 hypothetical protein
MIYYVVALSGILLLVLNNLKWMKIKRSISNTKKSKAKSTSSITILIKKIF
FEWIDYVSTHSKSTPHILLPICSLVIVYYINSTWINVNYSFVFIINIIFI
IVLQLKYARSKHYLLFKQDFPEVLLMINMAASSGASINQVLERCGKEIRG
PLGQELGLICRRLNLGETPETVFYDAYERFHYPEFYFLVTIILLNIQQGG
QLKELITRLSQIITKKKTTEQKKAVMTAQIRMSVNIISIMPMLFSFLLYL
LDPTTIEFVWQHPTGRFIIYYIIISEVIGILIIRKMLGKSL
>YPO3879 putative outer membrane usher protein
MVQARVILKKNFSGRRKALTLCITLILHIDTAFGQEEPQNFEFDESLFLG
TKYASGLTQLNKKNSITAGNYDAVDVLVNNKLFKRMSVQFIKDANSSEVY
PCLSDELLTAAGVELGRENSTPPKEPHVTEANTPITETHAPTNQCLPLST
RVKGASFRFDQAKLRLELSIPQALLQKRPRGYIERAEWQEGEKLAFINYS
ANAYRSDTRGQQKRTSDFGFIGLKSGINLGLWQVRQQSNVRYASNDSGSD
TQWNSIRTYVQRPIPQLDSQLTLGETFTDSTLFGSMSFLGAKMATDQRMW
PVSMRGFSPEVRGVASTNARVIIRQNGREIYETNVAPGPFVINDLFSTSS
QGDLNVEVIEANGSRSTFTVPFSAVPDSMRPGVSRYNAVIGESRDFTNID
NYFTDFTYERGLTNQLTANSGVRLAKDYTALLAGGVLGTPVGALGLNATY
SHAKVENDKTQDGWRMQATYSQTFNQTGTTFSLAGYRYSTKGYRDLNDVF
GVRSMQKNGGTWDSSTYKQRSQFTTTINQDLGNWGQLYASASTSDYYNDT
ARDTQLQLGYSNSYQQISYNLAVSRQRSVYTSTLYNWDSPDTDETATTTR
YGNTENIATFTVSIPLNIGSNNQYLSMSASRNPKSGNNYQTSLSGTAGER
NSFNYALNAGYDDSNFGSSSNNWGANVQKQFPNATVNGSYSRGNNYTQYG
AGARGAAVIHRQGVTLGPYLGETFGLIEANGAQGARIDSNGFALVPALTP
YNYNTIGLDTKGINRNTELKENQGRVVPYAGAAVKVKFETLTGYAVLIQA
EGEGLPLGADVYNSKDELVGMVGQGNQIYARIADNKGTLDVRWGESSGDQ
CQLPYAFNRQDTEQDIIHITASCRR
>YPO3881 putative chaperone protein
MLLLMTTCRVLTLPALTIGVLIMSALATSAVASVIAERTRIVFSEGSTEE
SLQLVNSNSYPVAVQVWVDDGNLMATPDKAVSPILVLPPVFRLQPQAQRS
LRLILSGGSKLPADRESAFWLNIYEIPPKATPKSGDESFVTLALRMQYKV
FYRPKNLPAPGDILGKALTFSLERNGDSALIKVNNPTPYYASFAALTIGS
AEGPPEMVAPFSQLDFPLNRAPISDNKTVNFDLIDDLGNRNSFSHELK
>YPO0302 putative outer membrane fimbrial usher protein
MVARCINLQCIAFLFSFFPTLAFPVTEEGEVVFDIETLERLGYSAELAKF
FSGQDRFLPGQHDVTIIINASKTYRIAATFDSEGKLCMDKALLMALKLRN
TESDGSCENMEARWPGMVVKLFPGQFRVEITLPQEAFDPEMEGSEYQQGG
HALLLNYNIFGQRVESNNSRFNLVQGQFEPGINFKNWVLRNRGSYSYNQG
VSQYYNQETSALRAVESLKSVVQLGEFGLVGNTFSGLPVTGIQLYSDNAQ
RDDTQLIVPIEGIANTNATIEIRQRGRVIYRTIVAPGPFSLSNISNFSSG
VNTDVSIIEEDGTQQNFTVTSALDINAEQQASIYQLAVGRYRDMFTGEDR
PSPLLLSGEMSFNPAATFYMTSAGLLSSGYQNIRVQNLYSGWDQAWFSAA
ASYANTKDAGQGYQFSVQNQMTINGNFGVSWSSVYGSANYWLPDDALSSS
NNLNDLMFGKLKNATSVAVSWVHPRWGAFSYALSNNMYYQASGRTYHIFS
ISEQFGRATTILSSQLSSQGQNSLYVGINMPLGNGTLSGRVQRNNGNVAL
GSTYQGRWGDNKDYSVGISGDNRQRRINGSMNIRTAYSQLTGGVSQATNN
SRSAYLSSRGSVAYVNNTFATSSSSVGDTFAVVNIPNQPGLRVSSPSSGI
AITDYAGIALLPLVRPYTASKVQISTQTLPLNIRLNNTSADLLMTRGSVA
THHFETTETRQLLLTIRGSDGEMLPIGANVLDEKGNFLGTIIGDGNFMLE
NKAIGVTLRVKANNRDECRVNYREPEKFDPDVLYEVADAVCQ
>YPO2045 putative hemolysin
MKINKFKLSPAGKLTVILSLILTPITNSYSAEIEAAGNTYMRGNEHIPSV
YNNPDGVSVINIAPPSEHGLSHNQYMEFHVNEHGVVFNNSLERVVKNGLT
YDANLNLRGSPARVILNEVVGPNASVLAGHQDIVGIPADYILANANGISC
QGCSFAPEFKNVTLAVGKVVTVRGDLRSIDTIGNANLLNVSNDRDDNNMA
DALTLIAPVISTNGHIKVKGDADFVVGQNMYHFMKDKTPEVEAGNSKIKT
IDGYYLGSISANRINLVDTREDNNINLFGDVTAEETKVVTSGTLRLRAAE
DGRQDITIKNGMNISANKIDTTREFTADEVKLFDIKENKVNKTIINAGRI
DFVAVEDVKLAGTTILSNDDLSITAKSLHVDSHLIKHSQDTGVVVTHVNI
LDAPTKKVEIKNNDHVSQASAIMSRKNVKLHGQDGLELKNANIQAYGNIK
LSSEGDIHLNGSTETNTTINNITYINYDEDLKRGHNNVETVTERFAPLDM
KARGNIDIQSKNTHIHGAKIASEGELSIDAKGDVYIGLASMLTSEFKDID
YNMWGGAHGSEKDKIEEYVYTGNKSDLVGGRVKITAGNDARILGGKINGV
DSGEISAQNYLSIDGVLGTRSFKRDQKTGGIMHTNESASTSQNHYEKFID
SEISSDGDFRIFSQKDLYIDGSRINVNGKLDINANEKLTVQAARQQQKID
EEKTRLSIEWFAKESSDKQYRAGILINHQKDTENTLRDEHQIATLSAEQI
NITAGDDIKFFGTGISTSKGDVIIKTPKNVGFFTAKNRALINKNQVNNSG
GFYFTSGMDKTGNGLQYTHIDKESYSDIENNLVVKTHIKGDLNINAGGDL
NQQGTQHDVAKNYSVEASNINNMASNNLAFSKTDTLQVDVSIGNNIDHSG
MTRPIEKVIKDPANTLDYIGGRGSQKGVSDPTIGLDVDVSGSRTKTSDND
ALALVTSIKAQDIKQVAKKDVLDEGTQYHATEGGMSLQGARHFSRAAVNS
KANTTEQEKGEVSLRGGMTATQEIKGHLGVKAETSQGDSYAEEMLVGNIN
AKSGVSIKTTGDAYYYATNIEGGNGDITIDAGNNLYFDQVQDSQRSSNIK
FSGHGKLSLGGSSGSKEFRLEGGGGYQQGRSQRTDAIVSKINTQGNVTLK
AGADLTTKGMQIGKQGTRASDVSLLAAGEVKLLAAVSGSADINDSALADF
RLGGKRATGGASKEGFVGAGVQADKVNQSVSDRQGGHIYSKNTVSIKSDS
DSNQAIHLEGLKIDAPKVDLSAQQGGVFIESALSELPKDNWNFGFNLDMV
LKNTSPKKEDGTIDKDKASESHYKGAGIKVMVDKQDMFKHQNAHINTAYF
SLNTKKDAVMKGARIESTRADVNVGRDLTIESLKSKEDSVKVDVELSLSH
TNDKSSSVTSKLSKVTLKKFEKRTQEKLDSGIKDIGLMYNNKVKPKDTMG
GVGFSKESQGVYLPTLSSETKSRNFADKTARYLGGQLKGIASGPEGLDGR
AKLDVQIVNNDAVAEQSGIFGIDETNISVKGTTKLHGAEISSGSGQLTLE
TENRELSNIKNSTHKGGVGLMFLLVY
>YPO2482 hypothetical protein
MPPLRSTRGKTVQGTQLDGAVIGSTATADKNTLDTGTLGFSDIDNQADFK
VEHQSVGISTGGNIGSQFVGNMANGLLVGANNEGHADSTTHAAVSEGMRA
ALLDIRVFMMSIYGVFYQSVEDIDFFIRETKEFSFPEDYQVPEHYNYRRE
>YPO4102 inner membrane protein translocase component YidC
MDSQRNLLLIALLFVSFMIWQAWQVDNNPQPTAQTTQQTTNTATGDKASQ
AVPGSGQGQLITVKTDVLSLTINTRGGDIEQANLLAYPDTLGSSNTFELL
ETTPSFVYQAQSGLTGKNGPDNPANGDRPLFEVPQTSFVLADGQDELRIP
LTFTSKDGSVFIKTFVLKRNDYAIGVDYHVNNASAAPLELTLFGQLKQSI
NLPKKRDTGSNNFALQTYRGAAYSSDETKYKKYSFSDIEDKNLDITTKGG
WVAMLQQYFATAWIPAANETNTFYSAELGNGLAAIGFKGAPVVIQPGEQK
QLSATLWVGPEIQNKMAEIAPHLDLTVDYGWLWFISQPLFKLLKFIHSFV
GNWGFSIIVITFIVRGIMYPLTKAQYTSMAKMRLLQPKLAAMRERIGDDK
QRMSQEMMALYKAEKVNPLGGCLPLIIQMPIFLALYYMLMSSVELRHAPF
ILWIHDLSAQDPYYILPILMGITMYFIQKMSPTTVTDPMQQKIMTFMPVI
FTVFFLWFPAGLVLYYIVSNLVTILQQQLIYRGLEKRGLHSREKKK
>YPO1920 probable fimbrial usher protein
MRIAPWLSCLLTQSLLVTHISSAADNNNQDDYIFDDALVRGSSLGLGSIA
RFNKKNSYDAGQYQVDMYMNNKFVDRLKMLFVDKDNSVEPCLSVAQLLQA
GVKEEALKTADPKTPCLAFQSILPASDFRFDHAKLRFDLSIPQKFVKNVP
RGYVDPKNLTAGNTIGFSNYNLNQYHVDYNKEGIKRTTNSTYLSLNSGIN
IGMWRFRQQGSLRYDASRGTNWTSNRLYSQRALPTIGSEITLGETFSSGQ
FFSSLGFLGVALSTDDRMLPESQRGYAPVVRGIARTNARVMVYQNNRSIY
QTTVSPGAFEFNDLSVTHFGGDLTVEINEADGSVSTFQVPFASVPESLRP
GYSRYSFAAGQVRDVGNNETFSELTYQQGISNAITANTGIRLASGYQAIM
LGGVFTHYIGALGLNTTYSHARLPDGEQQQGWMAKASFSRTFQPTNTTLS
VAGYRYSTDGYRDLSDVLGVRATSNDSSWNSSTYRQRSRAEISLNQNFHR
YGSLYLTASSQDYRDDRSRDSQLQLGYSNTFWRNTSFNLAISQQKTGGAN
KIYFVDPGSGMPASNGANTLATRETVAQMSISFPLGGSSSAPYVSAGAVN
SRTSGASYQTSLSGTMGSDQTAGYSVDVARNEPTNENTLSGSLQKQLPTT
SLSGSASRSPGYWQGSASARGSVAFHRGGVTLGPYLSDTFALIEAKGASG
AKVMYGQGARIDRFGYALVPTLTPYRYNTLSLDPDGMDFNTELQDGERQI
APYAGSTVKVTFRTLNGYPALITIKMPDGSQLPMGTVVYNYNGKGTNDKN
DIVGMVGQSSQAYLRAEELSGTLTLVWGESSKERCQLDYDLGKPTDNDKQ
LYKLDALCVAVQQ
>YPO1697 putative chaperone protein
MIKYHLLSKLILSFILLPIAPLHAAVSVLIWPIDPVINDDENATALWLEN
KDSQPTYMQIRVLSWRQVNGLDDYNAQTAIIASPPVANIQPGKRQLIRLV
KNAQVPAGKELAYRILIDEIPRQEPNDKNNPSSTQLGLTFQMRYSVPLFV
YGNGMQIAPEATQPTDIAQPTLSYILNRQQGKQWLTIRNQSEIHARISQV
TLNGQTVNNGLLGYVLARSQMSFPISLAARKGELAAIINSNTKPVTIPYQ
>YPO0271 putative type III secretion apparatus protein
MNNHMSSYHENAIIVHLATELLWLVLLLSLPVVVVASTVGLVISLVQALT
QIQDQTLQFLIKLLAVSATLLMTYHWMGATLLNYTQQSFLQITSMRP
>YPO0303 putative fimbrial chaperone
MQNFPTHHRDIGATIIYVNSVNRFNIFFVFTLLILLSSWSAVSYASFKLE
STTVILQESEARTSFTIDNISSNPILLVTKLTDLDGKSFSKQILISPPVT
RINAGQSQQVNFVLKKGSVLNNEVLLKASFEGVEQVPGNAAVMPIRQEIG
FLIQPSAVPQIRMPWQTLVFSISGNNLVIKNPGKHVVRLGPQIILVPSNE
VVALGNPYIMPETSKLFPITSSPTAVKVTPLSRYGFVQTEVTLPVTR
>YPO3823 putative lipoprotein
MYKKIVRFLAVGLLVAGLSACDNSSDNNVGQTVSLLDGKVTFNLPADLSD
QSGKMGNQANNMHVYANNTGDKAVIVILGEGTNEKLEVLTNRLAEQQRAR
DANLQVVTNKTININGQPFQQLDSIITSSGQKAYSSIVMGTVGNQLMTLQ
ITLPAENQQQAQTEAESIISTLKLK
>YPO1918 probable pili assembly chaperone
MRLLSLFLLLFTISYDALAGLIAGSTRIIYQPELRERTLMLANTNDYPVV
VQTWIDNGDVDSTPDQAKAPFMVLPAVFKMQAGSVQALRIINKGENLPSD
RESVYWLNLYEIPPRERSNIDVHAQVAMAMNTQMKIFYRPNGLAPPPIDA
MGKIKFSLKNIDNQYVIIANNPTPYFVSFGQIQLQSQQKNYLIAQSMDMM
TGPFSTRPYYFEQPPTSLKGKFTVSYIYFDDAGNQVKNSQSVTVTL
>YPO0682 MotA/TolQ/ExbB proton channel family protein
MDLSVWGMYQNADVVVKGVMIGLVLASIVTWTILFSKGTELFRARRRLRQ
EHEVIGAVTDLDTASERAEDFGQGSVSSLLLHEALNERLLSIESNDNNGI
KERTAFRLERRVAAIGRQMGKGNGFLATIGAISPFVGLFGTVWGIMNSFI
GIAHSQTTNLAVIAPGIAEALLATALGLVAAIPAVVIYNIFARQIGNYRA
QVGDVAAQVLLLLSRDLDLASSAEVKSPRHPHQLRAG
>YPO0598 putative hemolysin activator protein
MSRFYYSILVAGVLLKIVAIPDASYGAELAPVQQSIHQQERQRALEERLA
PPTPDVRLSAPSAFFSRIIFPLETPCFVINRIKISGAEPLPRWLPLQRIA
DQAQGQCLGAKGINLLMSQMQNRLVDHGYVTTRVLAPQQDLNSGTLALNV
VPGKIRGVELTPDSNRYVTLFSAFPARAGTLLDLRDIEQGLENLQRVPTV
QANMVLIPGSAPGETDIILNWQQRKMWRLAASLDDSGTRSTGRYQGGATL
FLDNPLSLSDLFYVSAGGALQRRGDKGTNNLTGHYSLPFGYWTAGMTASR
YDYYQAVAGLNGDINYRGESENVAFQLSRLLHRNASQKTTFTYDVLTRSS
KNYINDTEVEVQRRRTSAWRIGLQHRHFISQAILDAGISYQRGTRWFGAI
PAQEEYFGEATALSKILRLNAQLDIPFVVMAQNLHYNLQYQRQSTNTPLT
PQDQFSIGGRWSVRGFNGERTLIADRGWWVRNDIGWYLPLPGHELYVGVD
YGEVGGRSGAYLLGRHLAGSAVGVRGNVLNTRYDLFAGKPLSKPNGFKTD
SLAVGFNLNWLY
>YPO2944 putative pili chaperone protein
MLFGSVMFSKIIILVLSLTISSIPAFAAMTISGTRVIFPAAEKEVSIRTN
NKGVQPALVQVWVDDGKTNANINSMKLPFMVTPPVFRVEPGKGQTVRMIY
NGMALPQNKESVFWFNMLEIPAVKKEGNTQNKLELAFRTRIKVFYRPTSL
ESNSAAQSAQLKWTLVDDNQKGRGVKVVNPTPYYISFDSGSITVGAKSVE
IITDMVPPFSEKMFFPKLKLLGSTSISKMNYKILNDYGAAIDEELSFSQG
QGVLVSKKK
>YPO0808 general secretion pathway protein L
MKLTFTLLIRLGETEFEPIYWYVESQGKKLVRHGKINGVAELKNITLYAN
NVVKILVPANKIIFRSLSIKKNEVMNNIKSIAFSIEQSISSDIDNFHIVI
LDQDKDFCHVAAIEHELMNRWLFWLNINGISACCIMPDAFALPFFNSEWS
VIKIESNWLVRNNEMSGFLVNSSVLENILMLAEPTIKVNTFSPTDIKWGN
WQSLDYSDPVLIMAKTVSGNHVNLLSGKYKYAERIIVNNSVFLRVASWFF
LLFLVMSLNGWYQGYKIVRDTGALSKVAQDFYADFLPPAYHGGDVNTSFN
KYISDLDLKKNNVSFIKLLNAVSYYTADENVDVRSFNFNYSDGEISFDIE
GDDDLINEMLNDKTNLFNARVEVIRSGEDKYNIKLSSQP
>YPO0699 fimbrial chaperone protein
MKKLSLIALTSTVVFTSYTANAAIALDRTRIIYNGQDKSISLNISNENKT
LPYLAQAWIENEQQQKVTTPLVATPPVQRVEAGKKSAVRISATPEALKLP
QDRESLFYFNLREIPPRSEKSNVMQIALQTKIKLFYRPEGITPATGQIWQ
EQLVLHKTAQGFRLENPTPYYITVVGLAEKGKSSADSNFQPLMVAPKSSA
ELKSASFTAPVLTYINDYGGRPELSFSCSGSTCRAAKAI
>YPO2280 putative phage-related secreted protein
MKKILLALTLLFSSCAFAGSELELNKVKLPEAISLIYSEVLKVPYMLDPQ
LVNDERMITFRLTPDIDEREFVTRYLGNMNIRIWTKKGVDFIAPYTPKEP
VKPRYTWTYTPQYRSVAYLSDILGGYVSGSFNNSGAVISDDSLKGSSGAS
NYINRTGDILVYYGTKEDIAILKTLVTSLDTMSDEVVVSGYVFEVQTSQS
DGSGILLAAKILSDKFNISVGAAGLDNFINIRTGSIDAIFNLLKTDSRFT
VVSAPRLRVKNNASASFSVGSDVPVLGSVTVNNNTTTQSVEYRSSGVLFN
VTPSIKSRTMDLKIQQQLSNFVTTETGVNNSPTLIKRDVTTEVSLADGDI
ILLGGLAEQKDSKASSGWSFFGSRTSESNKTDIMVMLQVRKVDRSRATPR
SAARSGELFRDNLN
>YPO1711 putative chaperone protein
MKTLWLILRPRARKVNNLRTLLITAILSSLVLSATVQAGVAIGLTRVIVT
GADKSGSVQILNDGLHPALLQLWVDNNIAEMDKPIEQINVPFVVDSPVFR
LNAKTNKSIRIYYTGGANQLPSDRESMFWLNVLEVPPKASANQSSQNAVQ
IAFRSRIKLFYRPAGIPISSEGVATKLSFTLVPKGEGRVLRVANPTPFNV
TFQTLAIAQSHTAQGVTIKLGADDMVGPKSSVDSAPVGNNALAKNMSVFF
TIIDDFGSPIEGQQPLQ
>YPO3877 putative fimbrial protein
MKKITLAIALFSASTTVAMSASNNTITFQGEVTAQTCSVTVNGLEANPVV
LLPTVSSSDLDASGQTKGKTTFTLGVSGCTSGSDDLDIKTVFIGSLVTAT
GNLQNTGTAGNVELQLLKDATTTTGIDLNSGLAQDGIVLLAGDTSAEHDF
AVQYYATGQSTPGSVIASVQYAVSYL
>YPO0813 general secretion pathway protein G
MANKKTKGFTLLEIMVVIVILGLLASLTIPSLMSNKNRADQQKAVSDISA
LENALDMYRLDNGDYPTEQQGIAALVTKPNVPPLPQRYPSDGYIRRLPTD
PWGNSYQMNNPGKHGQIDIFSIGPDRLPETEDDIGNWITLSISET
>YPO2945 frimbrial protein
MRKLNLAVCAVALSVISSTSYAAAGGTVTFNGKLIADTCQVDTASENITV
TLPTLSIQSLAVAEAQDGSKDFEIKVLDCPATLTQVGAHFNAIDSSGVNP
ATGNLVNKAPTDAAGNVEVRLYNVDDSSQIRVGSTGNMVNIVKVGATPGT
ANLTYAGGYYATDATTPGEVNAKVEYVLAYN
>YPO2737 ccmD, putative heme exporter protein D
MTPAFHSWAEFFAMGNYAFYVWLAVAATLLSLLGLLMHTLWQHKQLLADI
HRRQAREQRIRQAQLNQTSMHQVPLHQAPLHQAPLQQAPQHIANLQEKRP
>YPO3157 clpP, ATP-dependent Clp protease proteolytic subunit
MSYSGERDQFAPNMALVPMVVEQTSRGERSYDIFSRLLKERIIFLTGQVE
DHMANLITAQMLFLEAENPEKDIFLYINSPGGVITAGMSIYDTMQFIKPD
VSTICMGQACSMGAFLLTAGAKGKRFCLPNSRVMIHQPLGGFQGQATDIE
IHAKEILKVKSRMNELMAYHTGKSLEEIERDTERDRFLSAEQSVEYGLVD
SVFTRRD
>YPO0075 cpxP, hypothetical protein
MRKVTTLVMASMFVLGSSAAFAADNTKVTEGYHGDGKMMMNKKGDRGHHN
MFDGINLTEQQRQQMRDLMRQSHQSQPRLDLEDREAMHKLITADKFDEAA
VRAQAEKMSQNQIERHVEMAKVRNQMYNLLTPEQKEALNKKHQERIEKLQ
QKPAAQPSSAQK
>YPO3296 ffh, signal recognition particle protein
MFENLTDRLSRTLRNISGRGRLTEENIKETLREVRMALLEADVALPVVRD
FINRVKERAVGHEVNKSLTPGQEFVKIVKNELISAMGEVNNELNLAAQPP
AVVLMAGLQGAGKTTSVAKLGKFLKEKQKKKVLVVSADVYRPAAIKQLET
LAQGVGIDFFPSDAQEKPIDIVNRALQQAKLKFYDVLIVDTAGRLHVDEA
MMDEIKQVHAAIKPVETLFVVDAMTGQDAANTAKAFNEALPLTGVVLTKV
DGDARGGAALSIRHITGKPIKFLGVGEKSDALEPFHPDRIASRILGMGDV
LSLIEDIESKVDRAQAEKLATKLKKGDGFDLNDFLDQLKQMRNMGGMASM
LSKMPGAGQLPENVKSQMDDKVTVRMEAIINSMTLKERAKPEIIKGSRKR
RIATGSGVQVQDVNRLLKQFDEMQRMMKKMKNGGLAKMMRGMKGMMPPGF
PGR
>YPO1797 flgM, negative regulator of flagellin synthesis
MSSIDRTQPLSPVTQVQARESHDVAQQTRQSATQTKTPVSGTEVKLSDAQ
AKLMQPGSQDINVERVETLKQAIRSGQLTMDTGKIADALLKNVADELKNH
>YPO1796 flgN, flagella synthesis protein FlgN
MVESLQTNLDQQLDLLESLTNVVAQEQQLLCSGRIQGWVLQGVTEQKSSI
LATLAYLDQTRITTETTANIQAPYTRMPALAERWQRLLQLTERLRYSNLH
NGLLLQQHIEHNNQALAVLNTRHGQSLYGPDGQAKGANILGRKIGI
>YPO1791 flhA, flagellar biosynthesis protein
MANLAALLRLPGNFKDTQWQILAGPILILMILSMMILPLPPFALDLLFTF
NIALSIMVLLVAMFTQRTLDFAAFPTILLFSTLLRLSLNVASTRIILMDG
HTGGAAAGRVVEAFGHFLVGGNFAIGIVVFVILVVINFMVITKGAGRIAE
VGARFVLDGMPGKQMAIDADLNAGLIGEDEAKKRRSDVTQEADFYGSMDG
ASKFVRGDAVAGLLIMVINVVGGLLVGVLQHNMAFGHAAETYTLLTIGDG
LVAQIPALVISTASGVIVTRVSTDQDVGQQMVTQLFNNPRVMVLSASVLG
LLGMVPGMPNFVFLLFTAALLALAWRLRGKQTQQPVAVEAPVVQDQQQGA
EATWADVQLEDPLGMEVGYRLIPMVDFQQNGELLGRIRSIRKKFAQEMGY
LPPVVHIRDNLELPPANYRILMKGVEIGSGEAHPGRWLAINPGNAVGTLP
GEATHDPAFGLAAVWIESALREQAQIQGFTVVEASTVVATHLNHVLSQYA
NELFGRQETQQLLDRVTQEMPKLTEDFIPGVVTLTTLHKVLQNLLMERVS
IRDMRTIIETLAEHAPNQADPYELTATVRVALGRSIAQQWFPGNGEIQVI
GLDAALERLLLQALQGGSGLEPGLADRLLDQSKQALQRQEMLGAPPVLLV
NHALRALLARFLRRSLPQMVVLSNLEIGDNRQIRMTSTIGSA
>YPO0706 flhB, flagellar biosynthesis protein
MSNSSGEKSEKPTAGKLSKARKKGDIPRSKDVTMAAGLVTSFILLSLFLP
YYKALVSQSFVSVAQLASQLDDQGALEQFLLANLFIFAKFLATLIPIPLF
SMLATLIPGGWNFTPVKLIPDLKKLSPLAGIKRIFSASNGTEVLKMLAKC
SIVLYTLYLVVHSSLDDLLHLQTLPLEEAITQGFAQYHHILLYFIAIVVV
FAAIDIPLSHHLFTKKMKMTKQEVKQEHKNNDGNPEIKSRVRQLQRQYAI
GQINKTVPSADVIITNPTHFSVALKYAPEKASAPYIVAKGKDDIALYIRS
IAQKHKIEIVEFPPLARAIYHTTKVNQQIPAQLYRAIAQVLTYVMQIKSW
RSGQASKPVLNTHLGLPKEMQRFHDET
>YPO1790 flhB, flagellar biosynthesis protein
MAEDSDQEKSEEPTASKLEKAREKGQIPRSRELTSMLMLGAGLTILWMSG
ESMARQLSAMVAQGLHFDHSMVSNDKQMLRQIGMLLRQTLLAMLPIFAGL
VIVALAVPMLLGGVLFSGESIKFDLKRMSPVAGLKRMFSSQALAELLKAI
LKATLVGWVTGLFLWHNWPDMMRLIAAPPVAALGDALHLIIFCGLVVVLG
LSPMVGFDVFYQITSHIKKLRMTKQDIRDEFKNQEGDPHVKGRIRQQQRA
MARRRMMVDVPKADVIVTNPTHYAVALQYNESKMSAPKVLAKGAGAVALR
IRELGAEHRIPLLEAPPLARALFRHSEVGQHIPATLYAAVAEVLAWVYQL
KRWKREGGLIPKKPEHLPVPEALDFATESETKSETD
>YPO1831 fliE, flagellar basal body protein
MSVQGIEGVLQQLQVTALQASGSAKTLPAEAGFASELKAAIGKISENQQV
ARTSAQNFELGVPGVGLNDVMVNAQKSSVSLQLGIQVRNKLVAAYQEVMN
MGV
>YPO0713 fliE, putative flagellar hook-basal body complex protein
MDNIDSINMPRSQSPVMLEMRQMAAMAGSGLEFGTIQPAATNSPFFPVEK
GANNLSFSQVLNGAIKSVDQLQHVASEKQTAMDMGISDDLTGTMLASQKA
SVAFSAMVQVRNKLTSALDDVMNTAL
>YPO1830 fliF, flagellar M-ring protein
MNASITGGENRENTFTMTLARLRANPKIPLLIAAAAAIAIIVALMLWAKS
PDYRVLYSNLSDRDGGDIVTQLTQLNIPYRFADNGGALLIPAEKVHETRL
RLAQQGLPKGGAVGFELLDQEKFGISQFSEQINYQRALEGELSRTIGTLG
PVLNVRVHLAMPKPSLFVREQKSPTASVTLALQPGRALDDGQINAIVYMV
SSSVAGLPPGNVTVVDQTGRLLTQSDSAGRDLNASQLKFTSEVENRYQRR
IENILAPMVGNGNVHAQVTAQVDFASREQTDEEYKPNQAANQGAVRSQQV
STSEQLGGTNVGGVPGALSNQPPVAPIAPIEIPQPAGAAANNAAPANTAA
TANANTTATAAKASSSNSRHDQTTNFEVDRTIRHTQQQAGMVQRLSVAVV
VNYTSDKAGKPIALSKDQLAQVESLTREAMGFSTVRGDTLNVVNTPFTAS
DDTRGSSLPFWQQQSFFDQLLNAGRYLLILLVAWILWRKLLRPMLAKKQV
ADKAAASVNNIVQTAQAAETVKQSKEELALRKKNQQRVSAEVQAQRIREL
ADKDPRVVALVIRQWMSNDQ
>YPO0714 fliF, flagellar M-ring protein
MLDKIKQKLSPGQLGENTKTILMSAVALLVTAAIIFSLWRSSQGYTALFG
SQENIPITQVVEVLEGEAIAYRINPDNGQVLVAENQLGKARILLAAKGIT
ATLPIGYELMDKESMLGSSQFIQNVRYKRSLEGELAQSMMALSAVEYARV
HLGMSEASSFAISNHADNSASVVLRLRYGQTLSTEQVGAIVQLVAGSIPG
MKPANVRVVDQHGELLSQAYQANSEGVPSVKSGTELAHYLQSTTEKNIAN
LLNSVIGANNYRISVSTQLDMSRIEETAEHYGPDPRINDENIQQENSNDD
MAMGIPGSLSNQPIPQSQAGQTPAAVSRSQAQRKYIYDRNIRHVRYPGYK
LEKMTVAVVLNKSLPVLEQWTPEQQEELKRLIEDAAGIDVKRGDSLTINM
MAFAVPTLIDEPVMPWWQEPSTFRWAELLGIGLLSLLVLWFGVRPLMKRY
SRKGSENLPLAISSASADEALDHVDTGVDGAESSPRTENAFSASSLWKSD
DLPEQGSGLETKIAHLQQLAQSETERTAEVIKQWINSNERIKSQPE
>YPO1828 fliH, flagellar assembly protein
MSDRINALPWQPWSLKDFASQSEAPLSESMPDISLLFPNEPMEATAAVDE
QQVLVNLQLEAEKQGRQQGFAKGLQEGLDKGYQTGLEEGHQQALADAQQQ
LAPMTAHWQVMVTDFQNTLDTLDSVIASRLVQIALAAAKQIIGQPAICDG
TALLAQIQQMIQQEPMFAGKTQLRVNPDDLAIVEQRLGSTLSLHGWRLLG
DSQIHAGGCKVSAEEGDLDASLATRWHELCRLAAPGEL
>YPO0716 fliH, flagellar assembly protein
MMLIKNTPRAGAVKLRVHQFPPLRKVRQVAPSAADQTLDPAEYQKQLMAG
FQEGISQGFDKGLAEGKEEGYQEGVRLGHDDGLKKGRIEGRQSELASFND
VIKPFSGYITQLHTYLETYEQRRRDELLQLVEKVTRQVIRCELALQPAQL
LTLVEEALAALPMVPQQLKVYLNPAEFGRINDVAPEKVQAWGLAADPDMV
GGECRIVTETTEIDVGCQHRLDQCIGALHSSFLTEPHHE
>YPO1827 fliI, flagellum-specific ATP synthase
MNCAVWPRRGNCDAPRLSRWLTSLDKFEERISQTTTIRRYGRLTRATGLV
LEATGLQLPLGATCLIERHNGGEVQEVESEVVGFNGQHLFLMPLEDVEGI
VPGARVYARVTTSGTSASKQSISSKQSIPSKQSFASKQLPLGPELLGRVL
DGSAKPLDGLPAPETGYRAPLITPPINPLQRTAIVQVLDVGVRTINALLT
VGRGQRMGLFAGSGVGKSVLLGMMARYTQADVIVVGLIGERGREVKDFIE
NILGAEGRARSVVIAAPADVSPLLRMQGAAYATRIAEDFRDRGQHVLLIM
DSLTRYAMAQREIALAIGEPPATKGYPPSVFAKLPALVERAGNGVSGGGS
ITAFYTVLTEGDDQQDPIADSARAILDGHVVLSRRLAESGHYPAIDIEAS
ISRAMTSLIDDDHYSRVRQFKQLLASYQRNRDLISVGAYAAGSDPLLDKA
IALYPQMEAFLQQGMFERSSFDDACQHLKVLFPG
>YPO0717 fliI, flagellum-specific ATP synthase
MSESPALDHALKSIENIHLARVAGRLVRVTGLLLESVGCRLAIGQRCRIE
SVDETFIEAQVVGFDRDITYLMPFKHPGGVLGGARVFPSEQDGELLIGDS
WLGRVINGLGEPLDGKGQLGGSTPLQQQLPQIHPLQRRAVDTPLDVGVNA
INGLLTIGKGQRVGLMAGSGVGKSVLLGMITRYTQADVVVVGLIGERGRE
VKEFIEHSLQAAGMAKSVVVAAPADESPLMRIKATELCHAIATYYRDKGH
DVLLLVDSLTRYAMAQREIALSLGEPPATKGYPPSAFSIIPRLAESAGNS
SGNGTMTAIYTVLAEGDDQQDPIVDCARAVLDGHIVLSRKLAEAGHYPAI
DISQSISRCMSQVIGSQQAKAASLLKQCYADYMAIKPLIPLGGYVAGADP
MADQAVHYYPAITQFLRQEVGHPALFSASVEQLTGMFPSFAPTDEA
>YPO1826 fliJ, flagellar protein
MKSQSPLVTLCDLAQKAVEQASTQLGHVRQSYQNAEQQLTMLLTYQDEYR
ERLNDTLCNGMASSSWQNYQQFIQTLEQAIDQHRKQLAQWSIKVEQAVKY
WQEKQQRLNAFETLQERAETTQRQQENRLDQKLMDEFAQRASQRSLNL
>YPO1822 fliN, flagellar motor switch protein
MSDPKFPSADGKESVDDLWAYAFNEQQATEKPTATTEGVFKSLEAPEGLG
NLQDIDLILDIPVKLSVELGRTKMTIKELLRLSQGSVVSLDGLAGEPLDI
LINGYLIAQGEVVVVADKYGVRITDIITSSERMRRLSR
>YPO0710 fliN, flagellar switch protein
MTDQQIELNNDLDFTLALDESAISPTEHFDSVINSPEIINTPEKTATKTD
EQKRKMSLFSRIPVTLTLEVASVEIPLSELLTVNNDSVIELDKLAGEPLD
IRVNGIMFGQAEVVVINEKYGLRIININSQNLGELAL
>YPO0709 fliP, putative flagellar assembly protein
MSRSLRAITPVTIISRGLLVGGLLYSPLLLAQEGGITLFNTVQTATGQDY
NVKIEILILMTLLGLLPIMMLMMTCFTRFIIVLAILRQALGLQQSPPNKV
LTGIALALTLLVMRPVWTKIHQDAVIPFQQDEITLSQALGRAEAPLKNYM
LAQTSTKSLDQMMAIAQVSGEPQQQDLSVVTPAYVLSELKTAFQMGFMIY
IPFLVIDLIVASILMAMGMMMLSPLIVSLPFKLMLFVLCDGWTLMVGTLT
ASVQGL
>YPO1820 fliP, flagellar biosynthesis protein
MSVINKTTLGLLTLFCSPSVLAQLPGIISQPLANGGQSWSLPVQTLVFIT
TLSFLPAALLMMTSFTRIIIVLGLLRNAMGTPSAPPNQVMLGLALFLTFF
IMSPVFDKVYQEAYLPFSQDKISMDVALDKGSQPLREFMLRQTRESDLAL
YARLANLPPLEGPEMVPMRILLPAYVTSELKTAFQIGFTVFIPFLIIDLV
VASVLMALGMMMVPPASISLPFKLMLFVLVDGWQLLLGSLAQSFYS
>YPO0708 fliQ, putative flagellar assembly protein
MTTDIAGDIIAMGLHLVLMISIVAIVPSLLIGLLVSIFQATTQINEQTLS
FLPRLVMTMLVLIFAGKWMMIKLSDFTVSIFQQAAQLVG
>YPO1820a fliQ, flagellar biosynthesis protein
MTPESVMALGTEAMKIALALAAPLLLAALISGLIVSLLQAATQINEMTLS
FIPKILAVFTTMVIAGPWMLNLILDYMRNLFTSLPTLIG
>YPO1819 fliR, flagellar biosynthesis protein
MLSFDTHQLSVWVSQYFWPLVRVLALIGTAPLLSEKQINKKVKIGLGVLI
TFLIAPSLPPVNIPLFSSAALWVAIQQILIGVALGVTMQFAFAAVRLSGE
VIGLQMGLSFATFFDPSGGPNMPVLSRLLNILVTLLFLSFDGHLWLISLL
ADSFHTLPIQFAPLNGNGFLTLAQSGSMIFMNGLMLALPLITLLLTLNMA
LGMLNRMTPQLSVFVIGFPLTLTVGIISLGLIMPLLAPFTEHLFSEFFDR
LAEVLSGMAN
>YPO0707 fliR, putative flagellar assembly protein
MGIDIHAMTAPLFALWLPFVRILSFLHFCPVIRHKAFTRKAKIGTALLLA
ILITPMISQPVVSGELLSIENLLLAGEQILWGWLFGSMLHLVLAALEAAG
QILSMNMGLGMAMMNDPTSGASTAVISQIIFTFSVLIFFTLNGHLLFVTI
LLKSFSSWPIGEAINDFSLRSLALSLGWILSSATLLALPTTFIMLIVQGS
FGLLNRISPTLNLFSLGFPIGMLFGLLCLLLLAINIPDHYLHLTNEILTQ
FERMKVH
>YPO0741 fliS, putative flagellar protein
MMYDEPMAGLYQQTDIAIQAAATPHQLVMMLFDGLRDELICAKGHIEAGR
YEHKVKSINKCINILNGLTSVLNYEDGGDLSVTISKLYDYCVYRLYEASN
LLSIEIIAEVEGILAALYQGWEGMKH
>YPO1840 fliS, flagellar protein FliS
MYKRSGSQAYAQVGLESGVMSASPHQLIVMLFDGAQSALIRARILMSQGN
IPAKGAAISKAIDIINNGLSAGLNLDKGGEMAENLSALYDYMSRRLLYAN
LHNDEQAINEVSALLENIADAWRQIGPNYQPN
>YPO3814 ftsY, cell division protein
MAKEKKRGFFSWLGLGRQSEEPAAEPLATEKEGVTEQEDVIEQTGVIEPT
DVIEQTVEHVISEKTTEAPAENAFIEVELREQVAAVIPTEPNNAIMSEGV
PDTLPERAVAESVVAELVETGDNAAIVHDEIIEPITQVTEAGGELSLVKP
GIEGDTTEQGGPTDNLPKRSLTEDNLIIDVPTPQAVVEESRVDAVEQPTE
TSEVEEVEEVEEVEEVEEVEEKIIPVAAQEQERPTKEGFFARLKRSLIKT
KQNLGSGFMGLFSGKKIDDDLFEELEEQLLIADVGVETTRKIITSLTEHT
SRKQLKDADALYGKLKEEMSEILSKVDKPLDVSGKSPYVILMVGVNGVGK
TTTIGKLARQFQAEGKSVMLAAGDTFRAAAVEQLQVWGERNKIAVVAQHT
GADSASVIFDAIQAAKARGIDVLLADTAGRLQNKAHLMEELKKIVRVMKK
LDGDAPHEVMLTLDASTGQNAVSQAKLFNEAVGLTGITLTKLDGTAKGGV
IFAIADQFEIPIRYIGVGEGIEDLRPFKADEFIEALFARED
>YPO3247 hmwA, putative adhesin
MNSKLYKLIFCRRLGCLIAVGEFTRSYGRAFSSKGGQAGNNQRRAVGILS
RLAMMTGLALGIFPLLVLAHPVLPVNGHVVIGQGMLDQQSSTLTVTQQTD
KLAINWDSFDIAHGHSVIYAQPGSQSIALNQVQGQSASQIYGRLQANGQV
FLLNPRGILFGKEAQVNVGGLVASTKYMSNPEFLSGDYRLIGGESEGNII
NQANLRSAPGGYIALVGNRIDNQRSGSITTPQGNTVLAVGHSVTLNLDHG
NLLGVQIQGETVAALIQNGGLIQADGGVIQLTAKGKDMLMDTVIDNTGIL
QAKGLSAKNGAIYLDGGGEGVVSQMGTIDVNNQQGRGGRAVVEGKRIYLN
KNSNIKAKGTAGGGTVLVGGGWQGKDNQIRNATAVVMDKGSDIDVSASRN
GPGGSAVLWSEDYTGFHGNIRARGGPQSGDGGQVETSSQRNLQAFGQVDA
SAVRGSAGYWLLDPAEVTIVSSGAESGVMTKVGNIPAEFFSSAHIFIPTA
NITQILNSSINTQLNSGTNVTITTSNSSLTGCQWCNITVQADITKTAGAD
ATLTLQADGNIVVNNNITADAGKLNLNLLAGNTTADSAITLNNSKVLLNG
GDFLAKHANDNNTARIGLLGGRYDVGNFTLDGNTALASQVGVNISNAANI
SVAGETVISGVSSNSRGQGWRGIDISNNSILTGVGNMTFSIGSNSNVSWM
GAFTNATITSDKNIIFQGTGSSSGGVDFVNSRILSKSGRVLFDINGNIVV
KNVYGLRVNNSQLSAKDVKFAVNVTGVDGFLLRDSHVTATSGDINANANT
INKGIWISGKTNLNASGNVNLHGVTTNSAYAGADAIKISGNSSSNNVNIT
AGGHISLIAVNGGKEIGSTVSVDYANIIAKNGDFNLNITGMKGSPFNNAT
ITANNISMNGNITANDAVLMTNTFLTAKGDIKTDLTSPTKGLWFRGNGGM
TAANNILLVANSTSSGETVKINASSSNKMNITAGKDISIIAGNSKTATGP
NINIENVNIETNNGNFTTNGITSTWLSGVNVSANGVDITSNSTGTGGIVL
DNTNILTTVGDINTIVTNSSGKGIWIKSNSTLNSNKDITLVGVSAGQNEG
VIIQGSSDASRNNISAQGNITLIGKMGNGSGQHSLINLGNVSLTSSGRNI
DINGSSAGTGDVYFTNVELNATAGNVSIYAETKTALSTSLNAVLSLGGNN
SIKAQNGWLIGKAFNTTQGAGIGFRANSSLSVDGNIILKGETEGVGATRK
GIDFYGANTLNIIKGSQLSLLGENKGAQDTAGGNGISYTSLAKLTVNNNG
SLKMEGRSTSGTGINFPSSNNTLVFNGDGDTLIKGSSVAGTGAAISGVVN
NSTGPMTIEGISTDGAGVHLFSAEHRIDRINVTGSSTHAEGLRISGNAAI
VDTTLTGKSINGSGVKIDSLPGSSVVTRSVLDNATLNGSSSSGKGVEITS
DINGIHHSSINGTTTGTGYGIDIGENSNVTGTSEADLLILQGVATTGTGT
GIKLNGNNDLSNTSLNSSAVDGIALDITGPLANQGNVILNGTASGSGIGA
QVNGSLSDSVVNGTSTNGIGVQINGSLKNSRINGISANGSGVKIDGESTL
DNATLNGNSTEGKGVDLAANLSGNHGSVVHGDTVHGTGIDVGKDVTLSGG
GTDEPLTVSGNASGEKGTGVQLGGNNTLDNTTLSGNATDGHGVEINSRLI
NNGNTTINGKTSDDGHGVHINGAISGGEINGHSDNSHGVFLDESALLNDI
VIGGGTGSYKLPVFIALPETIGERVTLNGKPIDKTQPEGSKAREGDNLTR
GKYTPLPPATDPELPPASTDEEKNTKQTSTLTPSQKREDPDMLIMARNHI
LSTLEGRDLSSSVVTESEQSAAGVTGIMVCLPLSETSEHEPCDTYILDKG
QPHLPMMVKK
>YPO3426 hofB, putative type II secretion system protein
MAEFIVSSFETISDELHLLCRRYRAVALTLDGKSLSIASAQTVDEALLTA
LRFTCGRQVRVEYWPEAKIEQSLYLGSPTKNNLNSSINNGLNSALLSQKG
GDPSRVKPHNQQQQTIDDTVFDNESDTPVIQFITQTLSLAIQKRASDIHF
EPYQHHYRVRLRIDGVLHEFTPPEAEWAARISSCLKVMAKLNIAERRLPQ
DGQLTLPFGDSHYSMRIATLPTQYGEKVVLRILQIQQQTTLEKLGMTDAA
LKQLTQALSAPQGLILVTGPTGSGKTITLYCSLARLNQTQRNICSVEDPI
EIPVNGINQTQVNSKIGLDFSRILRAILRQDPDVIMVGEIRDNETASIAV
NAAQTGHLVLSTLHTNSTAETLIRMAQMGIERHLIASSLKLVIAQRLVRR
LCLHCRQAASHPFIPPAHIRSGPIQHYLAVGCEHCCTGYYGRTGIYEMLS
VTPQIQQAILNNASPVKLVQIAQKQEQTALLCSGLALIEKGITTLSEINR
VVGFVAETEVTS
>YPO3427 hofC, putative type II secretion system protein
MSRHRLFNWTALNKTGELQTGMLLATERNSVYEHIIQHGLQPLGVKGGRR
LSARYWQGERLVAMTRQLATLLQAGLPLVNSLQLLAKEADDSAWRCLLDE
ISQQVAQGQSLSEVMEQYPHVFPRLYPPVVAVGELTGNLEQCCTQLVHHQ
ERQQNLHKKVIKALKYPVVVCIVALVVSVIMLVMVLPEFAQIYQSFDTPL
PGLTASLLWLSTFLTFYGPYLALIIAIVCIGYFYTLRKKSRWQQWEQTIL
LSIPLVSTLIRGSCLSQIFQTLAITQQAGLPLSAGLDAAARSIHNYNYQQ
ALRCIQKQISQGIPLYTTLNQHPLFPAICQQLIRVGEESGSQDVLLEKLA
CWHQQQTQNLADNVTQMLEPLLMLIIGSIVGVLVIAMYLPIFQLGDVIG
>YPO3248 hxuB, putative surface-exposed protein
MRDCYCHGMLWFPLKFSLLALFSLSCSPLIATPQVLNVPNAGAISNEIRQ
TTIEPLNAPEETDIKLPQLNKPTPPEGGLATERITLHRVRFEGDVSLFQP
GITADNKDLQALITPWLNRSLTFNDLQAMTFAVTRFYRKKGWVAAQAILP
PQTIRDGIIVVRVIAGRLDKPQINNQSSLNSHFITTVIESNSCSKKNGIF
GDKDCAASPVELSRLERTALILNEIPGVEASLALKPGTQSGMTRIYADVT
PGKKMMAYLAADNQGNDYSGHNRLLTGGVLNNLTGWGDQLRADLILSSSA
DVFNGLLDYNFPINSYGTRAALNYSYLDYTLTGPFSVLDARGHSTTWGIN
LRHPWIRTSAARIDVNAGYYQARMRDALILLPEQKRNLNAGEFGISGTFT
ALPRGLSNFNLLGTAGDLALDDEYSQSINTLTHVSGNFSRFNYRVGHDQG
IGSHVSFFNQFTGQMASKNLDSSQKLLLGGPLAVRAYGIGDGSVDKGTIF
TTELRTRWQPDFPDWAGYGHQITVAAFFDQGWGAYYRQPIVGLSENNINI
SGFGSYITFARPADYFLNLTWAHRTGQAVTRHQDNDQLWLSAYKMF
>YPO3481 ibeB, probable outer membrane efflux lipoprotein
MFSRILILSLPALLAGCISLDPDYQRPVAPVPATLPYSTASSSKAADIPW
QETIIDPKLRQVIALALESNRDLRQAIADIEAARAQYGVQRAAQIPTVNA
GVNGSRGRGLSDTSDGNNNTAISQSYGAQASVSAFELDLFGKKSSLSHAE
FETYLATEEAAKTTRITLIADTATAWVTLAADQNQLLLAEETLKSAEQSL
KLAQLRQKNGIASRIDVAAMETLYQSARADVAQYKTTVAQDKNALDLLVG
QPVAAHLLPVTASTLPEVIKAVPVGLSSDVLLNRPDVLEAEHKLKSANAN
IGAARAAFFPSVTLTASGGVSSSALSTLLSEGAGIWSLAPAITLPIFDGG
ANRAALEYSQAQKTGYIAAYEKAIQTAFKEVADALARKATIQEQRAAQQA
YVAAAQESVELAQKRYKQGIDTYLNMLDAQRTLYAAQTRLIAVQQIQTNN
LITLYKVLGGGVSDVAKE
>YPO2717 lepB, signal peptidase I
MANMFALILAIATLLTGIIWCFERFKWGPARQAKIAAVNAQTAEIKAQTG
CAVDNKTLAQAAKQPGWIETCASIFPVLALVFIVRSFIYEPFQIPSGSMM
PTLLIGDFILVEKFAYGIKDPITQTTLIPTGKPNRGDIAVFKYPLDPRLD
YIKRVVGLPGDRVIYNPISKEVTVQPSCNTGTSCDSALAITYSTSEPSEF
VQTFRYSGNGESSAGFFPIPLNQAVPDGGVRLRERTESLGPVAHHILTVP
GRQDPLGSYYQQPDQPLGVWVVPEGHYFMMGDNRDNSADSRFWGFVPERN
LVGKATAIWMSFEKQEGEWPTGVRLSRIGGIH
>YPO0476 lspA, signal peptidase II
MNKPICSTGLRWLWLAVVVVILDISSKQWVMAHFALYESVPLIPFFNLTY
AQNFGAAFSFLADKSGWQRWFFAGIAIGISVVLMVMMYRSTAKQRLINCA
YALIIGGALGNLYDRLVHGAVNDFLDFYINNWHFPTFNLADVAICIGAAL
VIFEGFLSPVEKNAVNNDE
>YPO2437 marC, multiple antibiotic resistance protein
MLSIFELFKAVGLGLVLLLPLANPLTTVALLLGLSGNMTREERNNQSLMA
AIYVFFIMTIAFYAGQIVMSTFGISIPGLRIAGGLIVAFIGFRMLFPQQS
AEDTQLEAKSQDLKKRKSINIAFVPLAMPSTAGPGTIAMIISSAATMKDQ
TMFAPWVLAIAPVITFLCVSLILWGSLLSSGAIMRWVGKSGIEAISRLMG
FLLVCMGVQFIINGVLELISTYQPVMA
>YPO1713 ogl, oligogalacturonate lyase
MAKGKQIPLTYHTYQDASTGAQVTRLTPPDVTCHRNYFYQKCFTRDGSKL
LFGGAFDGPWNYYLLDLNSRVATQLTEGRGDNTFGGFLSPEDDALFYVKD
GRNLMRVDLATLEENVVYQVPEEWVGYGTWVANSDCTKLVGIEIKREDWQ
PLTDWKKFHEFYFTKPCCRLMRVDLKTGESAVILQENQWLGHPIYRPYDD
STVAFCHEGPHDLVDARMWLINEDGSNMRKVKTHAEGESCTHEVWVPDGS
ALVYVSYLKGSSDRFIYSADPVTLKNRQLTSMPACSHLMSNYDGTLMVGD
GSDAPVDVQDNSGYKIENDPFLYVFNIKNGTQHRIARHDTSWQVFEGDRQ
VTHPHPSFTPDDKQVLFTSDVHGKPALYMVTLPESVWQ
>YPO3425 ppdD, putative prepilin peptidase dependent protein D precursor
MAKHQGLTLQKGFTLIELMVAVAIIAVLSGIGIPSYQRYIQKAALTDMLQ
AIVPYKMAVELCALEQSNLDSCNAGSNGIPAGQVSRYINAINIAKGVITL
SGQHTLTGLTLAISPTRNSNGNLVWARTCTATDSAMTDSCKAVFRFNDKA
PSNG
>YPO1304 psaB, chaperone protein PsaB precursor
MKNLFFSAYKKVFSYITSIVIFMVSLPYAYSQDVVVNTTKHLFTVKIGTT
RVIYPSSSTKGVSVSVANPQDYPILVQTQVKDEDKTSPAPFIVTPPLFRL
DAGLQGRVRIIRTGGKFPEDRETLQWLCLTGIPPKNGDAWGNTQNNPKNS
SPTMDIQMSISTCIKLLFRPDKVKGDPTDSADSLTWRYKGNYLEVNNPTP
FYMNFYSLRIGDEKINLSDLGSKDEIKNGSYVPPFSSRDFIIPVKNKGKA
TEVFWQVINDNGGVSREFKSTVQ
>YPO1305 psaC, outer membrane usher protein PsaC precursor
MKKLIVQFTTITLLMSTSFLVGAQRYSFDPNLLVDGNNNTDTSLFEQGNE
LPGTYLVDIILNGNKVDSTNVTFHSEKSPSGEPFLQSCLTKEQLSRYGVD
VDAYPELSPALKNSQTNPCVNLAAIPQASEEFQFYNMQLVLSIPQAALRP
EGEVPIERWDDGITAFLLNYMANISETQFRQNGGYRRSQYIQLYPGLNLG
AWRVRNATNWSQSGDRGGKWQSAYTYATRGIYRLKSRVTLGESYTPGDFF
DSIPFRGVMLGDDPNMQPSNQRDFIPVVRGIARSQAQVEIRQNGYLIYST
VVPPGPFELSDVIPSKSGSDLHVRVLESNGASQAFIVPYEVPAIALRKGH
LRYNLVAGQYRPANADVETPPVAQATVAYGLPWNLTAFIGEQWSRHYQAT
SAGLGGLLGEYGALSSSITQATSQYHHQQPVKGQAWEVRYNKTLQASDTS
FSLVNSQYSTNGFSTLSDVLQSYRQSGSGDNRDKIDENSRSRDLRNQISA
VIGQSLGKFGYLNLNWSRQVYRGPIPAKNSLGIHYNLNVGNSFWALSWVQ
NANENKNDRILSLSVSIPLGGHHDTYASYRMTSSNGSNDHEIGMYGQAFD
SRLSWSVRQAEHYGQPNSGHNSGSLRLGWQGSYGNIAGNYYYTPSIRQLS
ADVSGGAIIHRHGLTLGPQINGTSVLVEVPGVGGVTTTEDRRLKTDFRGY
SIVSGLSPYQEHDIVLETADLPPDAEVAKTDTKVLPTEGAIVRASFSPQI
GAKALMTITRANGQTIPFGAMASLVNQSANAAIVDEGGKAYLTGLPETGQ
LLVQWGKDAGQQCRVDYQLSPAEKGDTGLYMLSGVCH
>YPO0564 secA, translocase
MLIKLLTKVFGSRNDRTLRRMQKVVDVINRMEPDIEKLTDTELRAKTDEF
RERLAKGEVLENLIPEAFAVVREASKRVFGMRHFDVQLLGGMVLNERCIA
EMRTGEGKTLTATLPAYLNALSGRGVHVVTVNDYLAQRDAENNRPLFEFL
GLSIGINLPNMTAPAKRAAYAADITYGTNNEFGFDYLRDNMAFSPEERVQ
RQLHYALVDEVDSILIDEARTPLIISGPAEDSSEMYIRVNKLIPKLIRQE
KEDSDSFQGEGHFSVDEKSRQVHLTERGLILIEQMLVEAGIMDEGESLYS
PANIMLMHHVTAALRAHVLFTRDVDYIVKDGEVIIVDEHTGRTMQGRRWS
DGLHQAVEAKEGVEIQNENQTLASITFQNYFRLYEKLAGMTGTADTEAFE
FSSIYKLDTIVVPTNRPMIRKDLADLVYMTEQEKIGAIIEDIRERTANGQ
PVLVGTISIEKSEVVSAELTKAGIEHKVLNAKFHAMEAEIVSQAGQPGAV
TIATNMAGRGTDIVLGGSWQSEIAALEDPTEEQIAAIKAAWQIRHDAVLA
SGGLHIIGTERHESRRIDNQLRGRAGRQGDAGSSRFYLSMEDALMRIFAS
DRVSGMMRKLGMKPGEAIEHPWVTKAIANAQRKVESRNFDIRKQLLEYDD
VANDQRRAIYSQRNELLDVSDVSETINSIREDVFKTTIDSYIPTQSLEEM
WDIEGLEQRLKNDFDLDMPIAKWLEDEPQLHEETLRERILQQAIETYQRK
EEVVGIEMMRNFEKGVMLQTLDSLWKEHLAAMDYLRQGIHLRGYAQKDPK
QEYKRESFAMFAAMLESLKYEVISVLSKVQVRMPEEVEALEVQRREEAER
LARQQQLSHQTDNSALMSEEEVKVANSLERKVGRNDPCPCGSGKKYKQCH
GRLQ
>YPO0067 secB, export protein SecB
MSEQNNTEMAFQIQRIYTKDISFEAPNAPQVFQQDWQPEVKLDLDTASSQ
LAEDVYEVVLRVTVTASLGEETAFLCEVQQGGIFSVAGIEGTQLAHCLGA
YCPNILFPYARECITSLVSRGTFPQLNLAPVNFDALFMNYLQQQAEGEVE
GVEQRQDA
>YPO3189 secD, protein export protein SecD
MLNRYPLWKYLMLIVVIFVGLLYALPNLYGEDPAVQITGARGIAASETTL
VQVRDVLEKDNIASKSIALENGAILARFRDPDVQLRAREALVEALGDKYV
IALNLAPATPSWLAKLGAEPMKLGLDLRGGVHFLMEVDMDTALGKLQEQT
MDTLRTDLREKNIPYATVRKLDNYGVEVRFRDDKARNDAISYLSSRHRDL
VFSSNGSNTLKAVMSDERLREAREYAVQQNITILRNRVNQLGVAEPLVQR
QGSDRIVVELPGIQDTARAKEILGATATLEFRLVNTNVDASVAASGRVPG
DSEVKNTREGRPVVLYKRVILTGDHITDSTSSTDEYNQAQVNISLDSAGG
STMSNFTKDNIGKPMATLFVEYKDSGKKDANGRSILVKQEEVINVATIQS
RLGNSFRITGIDNPAEARQLSLLLRAGALIAPIQIVEERTIGPTLGSQNI
AQGLEACLWGLAVSILFMVVYYRKFGVIASTALMANLVLIVGVMSLLPGA
TLTMPGIAGIVLTLAVAVDANVLINERIKEEYRNGRTIQQAIHEGYKGAF
SSIVDANITTLITAIILYAVGTGSIKGFAITTAIGVVTSMFTAIVGTRAI
VNLLYGGKRINKLSI
>YPO3753 secE, translocase
MSANTEAPGSGRGLETAKWLIVAVLLVVAIVGNYYYREYSLPLRALAVVV
IIAVAGAVALMTAKGKATVAFAREARTEVRKVIWPTRQETLHTTLIVAAV
TAVMSLILWGLDGILVRLVSFITGLRF
>YPO3188 secF, protein export protein SecF
MAQDYTVEQLNYGRKVYDFMRWDYVAFGVSLLLLVASIVVMSTKGFNWGL
DFTGGTVIEINLENPADLDQLRDTLQNAGFESPILQNFGSSRDVMVRMPP
ATGTAGQELGNKIISVINESVDKNASVKRIEFVGPSVGSDLAQAGALALL
VALLSILVYVGFRFEWRLALGAVISLAHDVVITMGILSLFHIEIDLTIIA
SLMSVIGYSLNDSIVVSDRIRENFRKIRRGTPYEIMNVSLTQTLSRTIMT
SATTLMVVLMLFIFGGAMLQGFSLTMLIGVTIGTVSSIYVASALALKLGM
KREHMLQPKVEKEGADQPSILP
>YPO3499 secG, protein-export membrane protein
MYEALLVFFLLISIGLVALIMLQQGKGADMGASFGAGASATLFGSNGSGN
FMTRMTAVLATLFFVISLILGNMSSNQGQKSSEWENLGQPLKTEQTATPV
APVKPSSDIPQ
>YPO0229 secY, preprotein translocase SecY
MAKQPGLDFQSAKGGLGELKRRLLFVIGALIVFRIGSFIPIPGIDATVLA
KLLEQQRGTIIEMFNMFSGGALSRASIFALGIMPYISASIIIQLLTVVHP
ALAEIKKEGEAGRRKISQYTRYGTLVLAIFQSIGIATGLPNMPGMQGLVI
NPGFAFYFTAVVSLVTGTMFLMWLGEQITERGIGNGISIIIFAGIVAGLP
PAIAHTIEQARQGDLHFLLLLLVAVLVFAVTFFVVFIERGQRRIVVNYAK
RQQGRRVYAAQSTHLPLKVNMAGVIPAIFASSIILFPATIASWFGGGTGW
NWLTTISMYLQPGQPLYVLLYASAIIFFCFFYTALVFNPRETADNLKKSG
AFVPGIRPGEQTAKYIDKVMTRLTLIGAMYITFICLIPEFMRDAMKVPFY
FGGTSLLIVVVVIMDFMAQVQTLMMSSQYESALKKANLKGYNR
>YPO3720 shlB, hemolysin activator protein
MIRKRTALWLVLSTGAQAETPLAIETPSSINESRQSLQNNAKEINQLVEE
KRHQQITQHNTGQSELSRPAPPAPVLPEDTQCLPINGVYIQGITLLTEDD
LSELSAIPEQCIHPDNINLLTRELTHIYMDKGYITARIQFIPPDADGKLG
LDITEGFVEAIDSTDTGLDGETVFPNMIGKPLNITRLDQGLDQANRLPSN
KVTVDILPGTLPGGSILKLHNTPSTPWHLTTSMDNYGNKNTGKWLSRNAL
SFDNPLGLSDSVSINISNTVDRPQHNYSRAYSMFYSVPYGALTFSGFGSY
AEYRYPMKLQFNTAKLHGETQQHGLRADYVFYRDQSQINGLSAQLTYKRA
SNYLNEEKIAISSPTLTIFELGLNHLHVLPMGLFNINVSLEQGLPWLGAE
RSNGPLANYQDSQFTKAKTSITSNHYFALFDDTYLFSNQFYGQYTRDRLP
GVEWLSITDSSAIRGFSRNTLSADQGWYLQNTLSRRFTLGDATLTPRVGL
DTGRLQQKPQGWVSAMGLSAGVSLNYQNATLDIEASRGRLLSGPSKINDP
TQILARFSYRF
>YPO2216 sohB, peptidase family U7 protein
MELISLYGLFLAKVVTIVVAIGAVVLLVVSQGMRRQGQRGELNLVDLGEQ
YKETQREMRLARMSHAEQKAWVKEFKKQEKADQKLKKQRAKSGAVAAVKP
CLYVIDFKGSIGAQEVSSLREEISAILAVATAQDEVLLRLESPGGVVHGY
GLAASQLARLRQRGIRLTVAVDKVAASGGYMMACVADRIICAPFAIIGSI
GVVAQIPNFHRLLKKNDIDVELHTAGEFKRTLTLFGENTEQGREKFREDL
NETHLLFKQFVQQQRPSLDIDAVATGEHWFGTQAKEKGLVDAIGTSDDLL
IAEMDNHEVIGVRYSHRKRLIERFMGSATESVDSLLLRWWQRGEKPLL
>YPO2162 sppA, protease IV
MRTLWRIIAGFFKWTWRLLNFTRELILNLFLALLILIGVGIYFQFQSKPV
EPVKGALLVNLSGVIVDQPAINNKLRQWGRELLGASSNRLQENSLFDIVE
TIRLAKDDDNINGLVLSLSDLTGADQSSLQYIGKALREFRDTGKKIYAVG
DSYNQTQYYLASFANKIYLSPQGAVDLHGFASNNLYYKSLLENLKVTTNI
FRVGTYKSAVEPMIRNDMSAAAREADSRWVGGLWQNYLTTVSANRRLTPE
QLFPGAAGVISGLQVAGGSQAKYALDSKLVDQLAARPEVESALVEAFGWN
KKTNDFNYISIYDYQPTPAPQQGEQIAVLFANGAIIDGPQPPGNVGGDTL
AAQIRQARLDPKIKAVILRVNSPGGSVSASELIRAELAALRAAHKPLVVS
MGGMAASGGYWISTPANYIVASPSTLTGSIGIFGVINTFQNSLASIGVHT
DGVATSPLADVSLTKALPPEFSQMMQINIENGYKTFIDLVATSRHKTPEQ
VDQIAQGHVWIGLDAKSNGLVDQLGDFDDAVKKAAELAKLKTWQLNWFVD
EPSLSDLILGQMSASVHAMLPAAIQTWLPAPLSAMALAVKDQHGLFNTLN
DPQNRYALCLTCGDVR
>YPO3778 tatA, Sec-independent protein translocase protein TatA
MGSIGWAQLLIIAVIVVLLFGTNKLRTLGSDLGASIKGFKKAMGDDSQTP
PTNVDKTSNDADFAKSITEKQQPVAKAEESKSHEKEQG
>YPO3777 tatB, Sec-independent protein translocase protein TatB
MFDIGFSELLLVLVIGLVVLGPERLPVAVRTVSGWIRTLRSLAATVQNEL
AQELKLQELQDSLKKVEQAGLQNLTPELKASMDELKEAAEALKRSYHVDA
GSEAPHTIHNPLVTEPEAIHDGVTPAEPATQVSALAQAPNILEAGTASVV
DSVVEAAPVTTVKSVVQGEVLVKSTPVQEVGLADVMDKPVTKQQIDTIDS
HGTDLSSAGPSRIHQPGGDQ
>YPO3776 tatC, Sec-independent protein translocase protein TatC
MAVDDTQPLISHLIELRKRLLNCIITILVVFLVLVFFANDIYNLVSAPLI
KQLPAGASMIATDVASPFFTPIKLTMMVSVFVSAPMTLYQVWAFIAPALY
KHERRLMVPLLISSSLLFYLGMAFAYFVVFPLAFGFFAKTAPESVLIATD
ITKYLDFVMALFMAFGISFEVPIAIILLCWAGVTTPEALKKKRPYVFVGA
FVVGMLLTPPDVLSQTLLAIPMYLLFEVGVFFARFYTGKQRRAATEEDEG
IDSHPKAP
>YPO2597 tatE, twin argininte translocase protein A
MEGLSITKLLVVGILIVLLFGTSKLRTLGADLGAALKGFKKAMRNDDEVS
TSVLGETKMSAETKTVAETKAASDSQAAASVERKD
>YPO1124 tolB, translocation protein TolB precursor
MKQAFRVALGFLVLWASVLHAEVRIEITQGVDSARPIGVVPFKWMGPGTP
PEEIGAIVGADLRNSGKFNPIDAARMPQQPSTAAEVTPAAWTALGIDAVV
VGQVQPSADGSYVVSYQLVDTSGSAGSILAQNQYKVTKQWLRYSAHTVSD
EVFEKLTGIKGAFRTRIAYVVKTNGGKFPHELRVSDYDGYNQFVVHRSPE
PLMSPAWSPDGSKIAYVTFESGKSALVIQTLANGAIRQVASFPRHNGAPA
FSPDGTKLAFALSKSGSLNLYVMDLASGQISQVTDGRSNNTEPSWFPDSQ
NLAYTSDQGGRPQVYKVNINGGVPQRITWEGSQNQNADVSPDGKFLVLVS
SNGGAQHIAKQDLETGAVQVLTDTLLDETPSIAPNGTMVIYSSTQGLGSV
LQLVSTDGRFKARLPATDGQVKFPAWSPYL
>YPO0663 tolC, outer membrane channel precursor protein
MQMKKLLPLLIGLSLAGFSTMSQAENLLQVYKQARDSNPDLRKAAADRDA
AYEKINEVRSPLLPQLGLSAGYTHANGFRDASNSPDSNATSGSLKLTQTI
FDMSKWRALTLQEKAAGIQDVTFQTSEQQLILNTATAYFNVLRAIDSLSY
TEAQKQSVYRQLDQTTQRFNVGLVAITDVQNARASYDTVLAAEVAARNNL
DNALESLRQITGVYYPELASLNVERLKTQRPDAVNNLLKEAEKRNLSLLS
ARLSQDLAREQIKSAETGYMPTVDLTASSSITNTRYSGGTPSSQQVNNDS
GQNQIGVQFSLPLYSGGATNSAVKQAQYNFVGASELLESAHRNMVQTLRS
SFNNISASISSINAYQQVVISNQSSLDAMEAGYQVGTRTILDVLTATTNL
YQSKQQLADARYNYLINQLNIKSALGTLNMNDLMALNAVLDKPVPTSAAA
LAPENTTRQTVTTPRAQ
>YPO1121 tolQ, TolQ colicin import protein
MADMNILDLFLQASLFVKLIMLVLMGFSIASWAIIIQRTRILNAATRDAE
AFEDKFWSGIELSRLYQESQARRDTLSGSEQIFHSGFKEFARLHRANSHA
PEAVIDGASRAMRISMNRELEALETHIPFLGTVGSISPYIGLFGTVWGIM
HAFISLGAVKQATLQMVAPGIAEALIATAIGLFAAIPAVMAYNRLNQHVN
KLEQNYDNFMEEFIAILHRQAFASTESK
>YPO1122 tolR, TolR colicin import membrane protein
MARVRGRKRRELKSEINIVPLLDVLLVLLLIFMATAPIITQSVEVNLPDA
TDSKTVSSDDNPPVIVEVSGVGQYTVVVDHQRMELLPSEQVVAEAQARLK
TNPKTVFLIGGAKEVPYDEIIKALNMLHQAGVTSVGLMTQPI
>YPO3190 yajC, preprotein translocase subunit YajC
MSFFISDAVASAGAPAQGNSMTSMLIMLVVFGLIFYFMILRPQQKRAKEH
KKLMDSIGKGDEVLTSGGFIGRVTKVAETGYVVIALNDTTEVMIKRDFVA
AVLPKGTMKAL
>YPO2796 yapC, putaive autotransporter protein
MDKTLLAGAISLSLVILPVQVLAFTPNVVGITVNDEVVIHGIQNVRDGGV
INNGLVSDNAAITVTNGSSAGTANNTTVGDKGWLQITGALATGTIVNQGG
LLDTKTAGTVIDSQINDGGHMTLGLNSQSKGYLNIAAGAELFVTNNDPYI
SDVTTHNPALPANVMIENLNVAGLVEIGPSWKGTSIVPLPLSDVLGPVLV
TRINNVTLQGGDINLMAYSAGGQFNRLEIENLSGQGNFAMTTQLASNTGD
FITVSQQATGQFGITVQDSGKEPQSADNLALVHINRGDAQFRLLNTGGVV
DLGVYQYGLYSQESNGSTDWYLATSTEELPGTTPNVTAPMLSSAAQGVLN
MAAAPRHILNAELSTLRQRQGELKADAEGTVGVWARYLTDDSRLSDNKNI
AFKNTLSGMEIGADKQLGLNRGNMLIGAFTSYSSSDVKSTHDANGDIRSY
GGGLYLTYLDQSGFYVDTVLKANRFNNKMNTQETRGEYNQNALTTSVESG
YQWPVYANLVLEPYGKVSYSRIGSADYTLSNGMVAEVAKADSVQGELGTV
LAASYSINQMTIKPYIKLAITREFTKSNAVAINNIGFDNDFSGNVGKYGV
GINATVANNTAIFAEVDYLNGSKIETPVTANIGFRLRF
>YPO3984 yapE, putative autotransporter protein
MKTNRSTLSPCFRKTMIASLLVPLCSPLYSWAVQTASITDGSTMVISGGY
DTEANNHSAVFVQGSGSTINGGSDVVIETTGVGAIGAYASEGGSLGLTGS
TINTENGVAFGVLNDKGTVNLQGGTITTKGQTAYGVYSSGLGSNTDIHSS
AITTSYSLTHAIYGAGGTGLTLNNTTLNTSGSGSYGIYLDGSGGSLTGAN
NTINSTHATKGAGIYISAGGSNATLDNTTLNITKGAVGVNVGEGSSITMD
GLIATGNITNLFKVNGNASVSNANIELAAGGVLMAQGSSASNQAVIILNN
VNVISNSGSTTLVDVNKDADVTINGGAYHSKGNNAKGIWVRDNNSSLNVD
NAVIITEGVNATAIENRGTAIVKNTTVITKGNNSHGLYSEQSLDATNMAI
STAGIGSIGVAAAKGGNLNLNDAFIETTGNSGMVLGTFADSSISAKNITG
ISTGAGAYALWVDDGSSILLEESQITTQGQGAGGIYASNTGTGSHTAYTQ
VTLNNSQIHSEQGPGIWANGADINVDVKNGSQLTGGNGLLVYASSNAGAA
SNVNVNGDNHAVLLGDIHAAENSNINLALNNNSVWTGAATNAKQVDIDSS
SIWNLTGDADVESMHVLGQMNFISNSSDTNSRAPYDNFSTLTINSNVTGS
GSFTFNVQLGDNDSPVDRLYVIGNASGDHGVQVINQGGLGALTTGDGINL
ITVDGETHSGSFTMSNSVSAGAYEYFLYKIDDYRWNLQSNLINPGPGPEP
EIEPEEIAYRPEVPGYIAAPWLNAFYGFTTLGSLHERRGSAEGAAEGFNQ
DSWGRIRGQHNNFDAGRFSYDSNIWFMQLGHDVYQAKNAAGTQVTGGMMI
TLGKQNSDTRDRARAINPDLSIDTGKIKTEAYGFGGYYTLMTEEGGYLDI
VSQATLYRNNYESQHNTKHNGYGVVMSAEVGQPYPLAAGWVVEPQGQLKY
QYLHLSPKNFNDSISEIGGTDYSVGQVRGGLRLFSDASEKRDIKPYLTTD
VLHQLGRNPQVTVATVDIRPDFTKTFWQGGAGVTAKVNSQVDLYADAKYQ
KSFDGKLDGYLGNLGVKVSF
>YPO0606 yapF, putative autotransporter protein
MNNHKIWRLSAVAVALLISGNSYADQTLHFAQQPHNTGDHTVIAAPEVNN
FSLADLTANAEGQAVDATNAGALSLRVEPTQGDAQANGVLVTSGTFTNQA
QGSITVSASSQDQHAVASGLQATDAYWSTLRNQGSIRATSNSLHGSAEVY
GIQAGLAFSDAAGDHYGDHMMLSNEGVMQVSATAEQDAFASGIYTNAGNG
VVNNGRLDVSAHASAGDARATGLHTLSANPGVDPDPWNPANPTHLMSNNG
SLSVTASGNNATASAISTEGEGVYIYNNGTLIVDAFSESAQGGASAYGIH
VLNGSATINSSGRILATATGGSQQQAYEVMADGSVVNIERYTLALGNETP
WAVSNGGSIVLGNGTQGADLVLMAGQASEGFAYGKEYSLDNLAYDTTSGQ
QSTVGGSIAGLYGITPDIKVIHSGSSSSSLGSAALVYAPDVSHAGVSALA
QRSSMEQASNIISSQLHSQLVSNAGCNQKLESADSCVFITPYAGEYRRDP
VTSGYSGQRYGVLLGQNQHFGDFQLGWHGGYESASTDFNGTSVGRKEEIN
TLMLGVQGGMKLSESLFIAATSTWFSSDTDYSDSNTYYGVGSQSGSYDSS
GLYTDVSVGNSWQLNRNYAMTPMVGLTHIWQQRDGYTVSSNNKNYDLIDT
RYSSYSDHAVALHAGVRLDGRYPLTNETLLKPFFNVGFQQMLYGDEITID
QSIPNSPVVGVSTKDKTTQGTFDLGMALVSDNGVSASLQLSGMVNSDRQD
FTGWANLGWAF
>YPO1004 yapH, putative autotransporter protein
MNTIFKVIWNASLNVWVVVSELAKGRIKTKSSRNLISEGVLPKFEQSMVS
KLFRKNLLALSLGSIVFLSTGPVFAADITVSTQAELSAALSNGTYDKIIL
GADITLIGSLTVNMTSNQVVIDGQGKFGLTVNNTTNYGLVVSSGSGTLTL
QNMSKIDSANYYSMVVLNGANTAVNVIYNNIDFLGSSQLIYMGAYGAATN
SIMTFGDILNDVVVNDRAQEIGEVNKLAFTGRFHVTHTGSSVTSFVSTGG
ANNTSTMDFASGADVKIDRTGSTGDLTSTGVNAFAYTFADGASFELIANQ
NVFSGTTTNRGLEIGSYNSIDGFGSGVKIVLQSRSDGSIISGNGIDNATT
NAAGINNNASGDANVIYNLGTGSILKATNTGILATKNANNASDIYIRSAG
DITAATGISATHNGTGTVKIKNDGTITSTTAGIAISSASIKEISVDNTDG
TITATAGTGVNVLASAILNLFGGTINTSATANGITFAGTEGGHTLTDLTI
NLLGTGIALSNVAGVNLTLSNVTLNTLNGTALNSLTGLTLVDSLNGRNTI
NIEGAGIGIAATNTELNTFDAEALDINVNGAGIGIQATGGGVNLSASNLI
INVANTLGTALQITDGIDNTTTIGNEIQLNAENATAINFLGSSSKTLNNN
GTIKGSVIFAGVADHIINNNGTLDGTLTTGAGNDTLVLDSSSQSNDVINL
GDGNNSVTIQNGATVSSIITGNGNDTFTINGMSVGSTYLGSLDAGTGLNT
LNFNASTDELAAATSLQGFTNINLVDSHITLVSDDNIGSGMVNIDSSSEL
LFGSTFDGILHATLGAGTGSAIVNNSANVSLEQASMFAGTWQVNQGGALT
ASNSNQLGSAKIGLDGTLNLDNIALFNHVLTGNGTLNVAKNLATTAFDFG
STVGGAFSGIVNLTKTTFALSADNAAALASATLKLSDDSVTTVGTTDRTL
HGLDLSGGTLIFDGAVPQSQTSGVVTVTDLALNSGTVNITGSGSWDNTDP
LATNVSILEQDRAGSTLELINATNVTGDIDALDLLVNGTAITSGTQGVQS
AIQQGGSTVANAIHNYGLASSNSNGDSGLYVNYTLSALELLADGADALLL
ATESGLTANRVLNAELFGVGGLVVDAQNGALTLANGSNRYEGTTTVTAGE
LILGANGAFGQTSLLDIASGASANINGYSQTVGAVTNVGTVTLGSGGVLT
SGLLTNGGILDLTGGALNLTAGGASTVAGGLTGAGTLNINGGNLSVSAAN
SGLSGQTHIADVASVTLTDTGTLGTSAVEVLGTLNLNGANAAMTNVLSGD
GTINTNAAVTLSGNNSFSGAHQIGTDGELTVGQASNLGASSATVNLGTLT
SHLILNGVSESIANVLSGVAGSTVDIIGGADTALTANNSGFLGQYALAGN
SKLTVASTNNLGASSSVALAGAGDTLSLSGFNGTFGNSVTGSGVLQVTDD
AEVTLTSSNGVSNAVTIDIADATLNLDDIALFNHVLTGNGLLNVAKNDAS
TAFDFGSTVGGAFSGIVNLTNTTFALSADNAAALARATLKLSDDSVTTVG
ATDRTLHGLDLNGGTLIFDGSPPQSQANGVVTVTDLALNSGTISITGAGN
WENEHPVTPPNVSLLEQDRGDILLELINAANVTGNANNLDLLVDGTAITS
GTQGVESAIQQGGSTVANAIHNYGLTSSNGNGGSGLYVNYTLSALELLAN
GANALLLATESGLTANRVLNAELFGVGGLVVDAQNGALTLANGNNRYEGT
TTVTAGELILGANGAFGQTSLLNIASGASANINGYRQTVGAVTNSGAVTL
GNGGVLTSGLLTNGGILDLTGGALNLAAGGSSTVAGGLTGAGTLNINGGD
LAVSATNSGLSGQTHIADVASVTLTGTGTLGTSAVEVLGTLNLNGANAAM
TNVLSGGGVINTNAAVTLSGNNSFSGAHQIGTDGELTVGQASNLGASSAT
VNLGTLTSHLILNGVSESIANVLSGVAGSTVDIIGGADTALTANNSGFLG
QYALAGNSKLTVASTNNLGASSSVALAGAGDTLSLSGFNGTFGNSVTGSG
VLQVTDDAEVTLTSSNGVGNTVKVDIADATLNLNDIALFDHVLTGNGTLN
VAKNLATTAFDFGSTVGGAFSGIVNLTNTTFALSADNAAALARATLKLSD
DSVTTVGTTDRILHGLDLNGGTLIFDGSPPQSQANGVVTVTDLALNSGTI
SITGAGNWENEHPVTPPNVSLLEQDRGDILLQLIDADNVTGNANDLELMI
NGTTISAGQGVQSTVQQGGYTVANATHNYGMTSNGGSGLYVNYTLSALEL
LADGANALLLATESGLTANRELNAELSGVGGLVVDAQNGALTLANGNNRY
EGTTTVTAGELILGANGAFGQTSLLNIASGASANINGYRQTVGAVTNTGT
VTLGNGGELTSTDTLINTGMINVTDGILNLENGGASSISGGLTGNGILNI
KGGDFTISIDNNGLAGQTNISDGASVTLGNGGTIIGTGNLGSSVIDVLGD
LNLVADNSLANVISGDGTINTTATVTLSGNSSFSGAHQIGTNGELTVGQA
SNLGASSATVNLGTLTSHLILNGVSESIANVLSGVAGSTVDIIGGADTAL
TANNSGFLGQYALAGNSKLTVASTNNLGASSSVALAGTGDTLSLSGFNGT
FGNSVTGSGVLQVTDDAEVTLTSSNGVSNAVTIDIADATLNLDDIALFNH
ALTGNGLLNVAKNDASTAFDFGATVGGAFTGTVNLNNSTFDLSGNNTTVL
AQATLKLSSGNLTSVGNGVQNIGTLAMNGGTLLFDNIVDNAGIITSDGTI
AANSINTTGGGEVRVNLPSNLAPSLDGLSVMELDEGEIIVTLATGAATGT
GHELTLTDENGDPISAVTYQGVHNAGSTSAAATGSFNYGMTTGEDYDGLY
VNYGLTALELLSTGSEALVLTAILANNGTQSNDLSAQITGSGDLAFASAN
DGSTASLSNSTNSYTGTTWVSSGNLRLDADSALGQTSLLAMSTATHVDIN
GTQQVVGELATEGGSTLDLNDGKLTVTGGGQIDGALTGGGELVLSGGLLN
VSYDNAGFTGSTDIANGAVAHLSQAQGLGNGTINNNGTLHLDNTIGTLFN
ALTGSDGEVLLSNNASVQLAGDNSGYSGLFTNQAGSILIANSAEHLGGSS
IANSGALILDTGSVWELTNTISGTGTLVKRGSGTVKIEGDTVSAGLTTIE
EGLLQLGSSAVTQTLSLEESLQERALLVSFASNMANLTSNVLITANGSLG
GYGQVTGNVENYGNLIMPNALTGGDFGTFTIDGNYTGDEGMITFNTILAG
DTSVTDRLVITGDTAGQSYVTVNNIGGVGARTFEGIKIIDVGGDSAGQFT
LNGRAVGGAYEYFLYQGGASTPDDGNWYLRTEADDRRPEPASYTANLAAA
NNMFVTSLADRMGETLYTDVFTGEQKTTSLWLRNEGSHNRSRDDSGELKT
QDNRYVMQLGGDVAQWSRNAQDLWRVGVMAGYANSSSSTVAQVAGYRSTG
SVDGYSVGIYGSWLADNADDTGAYVDSWVQYSWFDNRVSGQDLATEKYDS
KGFTASVEGGYAFKVGESVNQSYFIQPKAQVVWMGVKADDHTETNGTVIS
GDGNGNIQTRLGAKAFINPSDKAKVSGPAFKPFVEANWIHNTKDFGTTLD
GVTVKQAGTANIAELKLGVDGQVNSQLNLWGNIGQQVGNKGYSETSVVLG
VKYNF